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Abstract 
Sumoylation is a post-translational modification that regulates numerous cellular processes including gene 
expression. We find that among the general transcription factors of RNA Polymerase II (RNAPII) in 
budding yeast, transcription factor IIF (TFIIF) shows a relatively high level of sumoylation, primarily on 
Lysine residues (Lys) 60/61 of its Tfg1 subunit. Fractionation analysis indicates that sumoylated Tfg1 is 
associated with chromatin, but its sumoylation level is not affected by stresses. Although Lys 60/61 were 
previously implicated in the Tfg1-RNAPII interaction, a Lysine-to-Arginine K60,61R mutation, which 
dramatically reduces Tfg1 sumoylation, does not affect that interaction. Chromatin immunoprecipitation 
analyses did not conclusively determine whether reducing Tfg1 sumoylation affects the recruitment of 
TFIIF or RNAPII to target gene promoters, but the expression of some genes is elevated in yeast expressing 
the K60,61R mutation. Our results demonstrate that chromatin-associated TFIIF is constitutively 
sumoylated which might be necessary for controlling the expression levels of some genes. 
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Chapter 1: Introduction 
1.1 RNA Polymerase II-mediated Transcription  
As the central machinery involved in the expression of all eukaryotic protein-coding genes, RNA 
polymerase II (RNAPII) is important for all aspects of cell function, including regulating cell differentiation, 
maintaining cell identity as well as establishing the cellular response to environmental changes. Prior to 
initiating synthesis of RNA transcripts, RNAPII assembles on target promoters with multiple general 
transcription factors (GTFs), including TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH, to form a structure 
known as pre-initiation complex (PIC) (1). In mammalian cells, to begin the PIC assembly, TFIID, which 
contains the TATA box-binding protein (TBP) and multiple TBP-associated factors (TAFs), is required for 
recognizing the promoter region. In particular, the sequence-specific binding of TBP to the TATA box 
promoter element occurs ~30bp upstream of the transcription start site (TSS) (1). Although the consensus 
TATA sequence is not observed in most promoter regions in budding yeast, TBP can still bind to these 
promoters, which are located around 40-120bp upstream of the TSS in that organism (2). Therefore, this 
binding is considered functionally conserved from yeast to human. During the next step of PIC assembly, 
the binding of TFIIB and TFIIA to TBP results in the recruitment of RNAPII-TFIIF complex (1) (Fig 1). 
As a critical GTF, TFIIB plays a role in both RNAPII recognition and TSS selection (3). This promotes the 
formation of the core initiation complex which shares high similarity between human PIC and yeast PIC. 
The later involvement of TFIIE and TFIIH not only completes the PIC assembly but also contributes to the 
opening of the promoter region as well as to the stabilization of the melted DNA strands (1, 3). 
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Figure 1: Schematic of pre-initiation complex (PIC). A canonical model for the early steps of PIC assembly from 
general transcription factors (TFIID, TFIIB, TFIIA, TFIIF, TFIIE and TFIIH; various colors) and RNA Polymerase II 
(Pol II; grey) on promoter DNA. The names for the intermediate complexes are shown on the left. Unbound promoter 
DNA is recognized by TATA box-binding protein (TBP) subunits of TFIID, inducing a bend of DNA. The recruitment 
of TFIIB and TFIIA stabilizes the TBP-DNA complex. The resulting upstream promoter complex and Pol II-TFIIF 
complex join together forming the core PIC. The later binding of TFIIE and TFIIH finish the PIC assembly. 
Reproduced from (1). 
1.2 TFIIF Subunit Tfg1 
Around 50% of all RNAPII is found in a complex with TFIIF in yeast (4). The functions of TFIIF include 
preventing the non-specific binding of RNAPII to DNA, stabilizing TFIIB binding within the PIC and TSS 
selection (1, 3). What’s more, TFIIF also plays a role in stabilizing the RNA-DNA hybrid and stimulating 
3 
 
 
phosphodiester bond formation when the initial transcribing complex forms. During transcription 
elongation, TFIIF also has multiple functions, such as shortening RNAPII pausing time (5). In yeast, TFIIF 
contains three subunits. Tfg1, the largest subunit (82.2 kDa) of TFIIF, and Tfg2 are conserved from human 
to yeast. Their human counterparts are Rap74 and Rap30, respectively. The nonconserved subunit Tfg3 is 
also involved in several other gene-regulating complexes (6).   
1.3 The Interaction between Tfg1 and RNAPII 
The N-terminal regions of Tfg1 and Tfg2 form a dimerization domain while winged helix (WH) domains 
are structured at the C-terminal regions of both subunits when binding to RNAPII (5). Other than these 
structural similarities, the architectural difference is also observed. Tfg1 has a charged region between its 
dimerization domain and WH domain, whereas Tfg2 only has a linker region between the two domains (5) 
(Fig 2). Further cross-linking analysis reveals that Tfg1 is involved in both intra- and inter-protein 
interactions. Not only Tfg2, but also several RNAP II subunits, such as Rpb1, Rpb2 and Rpb9, can interact 
with Tfg1 (5) (Fig 3). For example, both Tfg1 Lys 60-Rpb2 Lys 606 and Tfg1 Lys 61-Rpb2 Lys 606 are 
cross-linking pairs with high confidence (Appendix Table 1). 
 
 
 
 
Figure 2: Schematic of TFIIF subunits and domains. TFIIF contains three subunits. Tfg1, the largest subunit in 
TFIIF, forms a dimer with Tfg2 via the interaction of dimerization domains of these two subunits. Both Tfg1 and Tfg2 
have a C-terminal winged helix (WH) domain. A charged region is found in Tfg1, and a linker region is present in 
Tfg2. Dashed lines show cross-linked residues as determined from a cross-linking and mass spectrometry analysis of 
the complex. Reproduced from (5). 
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Figure 3: Cross-linking analysis of the complete TFIIF-RNA Polymerase II (RNAPII) complex. Map illustrates 
links within the TFIIF-RNAPII (dashed lines) identified by cross-linking and mass spectrometry analysis. Links from 
TFIIF to PNAPII are colour coded by the respective RNAPII subunits. Links within TFIIF subunits (grey) and between 
TFIIF subunits (blue) are also shown. Reproduced from (5). 
1.4 Post-translational Modifications  
Cellular processes are very dynamic and rely on appropriate protein activities (7). Changing of protein 
activities may affect the protein-protein interactions as well as the interactions between proteins and other 
molecules including carbohydrates and nucleic acids. This may lead to the disruptions of cellular events 
which then cause abnormal cell growth, cell differentiation and so on. As one way to regulate protein 
functions, the amount of protein is controlled by the rates of protein biosynthesis and degradation (7). 
Another way is through post-translational modifications (PTMs). PTMs are covalent chemical processes 
that alter protein structures enzymatically either by adding modifying groups to amino acids or by 
proteolytic cleavage (8). These modifications contribute to the heterogeneity of protein population and, as 
well, the complexity of the cell. Some commonly studied PTMs include phosphorylation, acetylation, 
methylation, glycosylation, ubiquitination and sumoylation. Dysregulating of these PTMs is found to be 
highly related to human diseases, for example, cancers, diabetes and a couple of neurological disorders (8, 
9).          
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1.5 Sumoylation  
1.5.1 Sumoylation and Ubiquitination  
Sumoylation is a PTM which can affect protein stability, enzymatic activities, subcellular localization, 
protein-protein interactions, or protein-chromatin interactions (10). SUMOylated proteins have been 
involved in regulating cellular progresses such as cell cycle progression, transcription, nuclear translocation 
and DNA repair (9, 11, 12) (Fig 4). SUMO (small ubiquitin-like modifier) is reversibly conjugated to one 
or more Lysine (K) residues of the target protein giving rise to a monosumoylated or a polysumoylated 
form (9). In most cases, the targeting of SUMO to lysine is directed by the consensus sequence ѰKxE/D 
(where Ѱ is a large hydrophobic residue and x any amino acid) (13). However, other studies showed 
multiple other consensus sequences, such as a phospho-dependent sequence, reverse consensus and non-
consensus regions, can also direct SUMO to acceptor proteins (14, 15).  
 
 
 
 
Figure 4: Sumoylation functionality in nuclear processes. Small ubiquitin-like modifiers (SUMOs) are nearly 
exclusively found in nucleus. Sumoylation, a process conjugating SUMO to substrate proteins, is highly involved in 
the dynamic nuclear processes including DNA repair, cell cycle regulation and transcription regulation. Reproduced 
from (28). 
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SUMO is conserved from human to yeast. In human, five SUMO paralogues are currently known (11, 16). 
SUMO1, 2 and 3 are the three main isoforms that are ubiquitously expressed, whereas SUMO4 and SUMO5 
are only expressed in certain organs or cell types (11, 17). SUMO2 (also known as sentrin 2 and Smt3b) 
and SUMO3 (also known as sentrin 3 and Smt3a), which are often collectively referred to as SUMO2/3, 
show 97% sequence identity with each other, excepting the three-residue difference at their N-terminal 
regions (9, 16). Similar to SUMO2/3, SUMO1 (also known as UBL1, sentrin and Smt3c) is around 11 kDa. 
SUMO1 shares approximately 50% sequence similarity with SUMO2/3 (16, 18) (Fig 5). There is only one 
SUMO protein isoform in the yeast Saccharomyces cerevisiae, which is known as Smt3. Smt3 is ~45% 
similar to the three main human SUMO isoforms (16, 19) (Fig 5). Both Smt3 and SUMO2/3 are able to 
form a polysumoylated chains whereas SUMO1 cannot (19).          
 
 
 
 
Figure 5: SUMO family proteins. The alignment shows the sequences of human ubiquitin, SUMO-1, SUMO-2, 
SUMO-3, SUMO-4 and yeast Smt3 (Smt3p). Residues identical in all proteins are shown on a blue background. The 
C-terminal di-glycine (GG) motif that is important for the maturation and conjugation of SUMO is also shown on a 
blue background. Purple background indicates residues that are only conservative changes across all four proteins. 
Residues showing semi-conservative changes among each of the proteins are shown on a yellow background. 
Reproduced from (16). 
1.5.2 Sumoylation Machinery 
The process of sumoylation involves a cascade of enzymatic activities which is similar to that of 
ubiquitination (16, 20). The three major enzymes are the activating enzyme E1, conjugating enzyme E2 
and the ligase E3 (16) (Table 1).  
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Table 1: Protein families involved in sumoylation machinery. SUMO isoforms, SUMO E1 activating enzymes, 
SUMO E2 conjugating enzymes, SUMO E3 ligases and SUMO proteases in yeast and mammals are listed. 
Reproduced from (16). 
 
 
 
 
 
 
Protein family Yeast (Saccharomyces cerevisiae) Mammals 
SUMO Smt3 
 
SUMO-1 
SUMO-2 
SUMO-3 
SUMO E1 (activating enzyme) Aos1 
Uba2 
SAE1 
SAE2 
SUMO E2 (conjugating enzyme) Ubc9 Ubc9 
SUMO E3 (ligase) Siz1 PIAS1 
Siz2 PIAS3 
 PIASxα 
 PIASxβ 
 PIASy 
 RanBP2 
 Pc2 
Mms21 Mms21 
 HDAC4 
 HDAC7 
 MUL1 
 Rhes 
 TOPORS 
 TLS 
 TRAF7 
SUMO proteases  
(SUMO proteases and isopeptidase) 
Ulp1 SENP-1 
 
Ulp2 SENP-2 
  SENP-3 
  SENP-4 
  SENP-5 
  SENP-6 
  SENP-7 
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Starting with an inactive precursor, the immature SUMO is cleaved at the C terminal region by members 
of the SENP family of sentrin/SUMO-specific protease (20) (Fig 6). In yeast, Ulp1 has the same protease 
activity as SENPs do in humans (16). This allows the exposure of a C-terminal di-glycine (GG) motif that 
is needed for SUMO conjugation (12). Then, this mature form of SUMO undergoes an activating step in an 
ATP-dependent manner. This activation of SUMO is carried out by E1 enzyme which reacts as a 
heterodimer of SAE1 (SUMO-activating enzyme E1) and SAE2 in human (21). The yeast form of the E1 
enzyme is a heterodimer of Aos1 and Uba2. A thioester bond is formed between the active-site cysteine 
residue of SAE2 and the C-terminal glycine residue of SUMO before SUMO is transferred to Ubc9 
(ubiquitin-conjugating 9) via another thioester bond (22). Ubc9, as the only known E2 enzyme in both 
human and yeast, can bind to specific lysine acceptors located in either SUMO consensus motif or several 
non-consensus regions of the target protein directly (16). Linking SUMO to Ubc9 promotes the conjugation 
of SUMO to the SUMO targets. In ubiquitination, there are two types of E3 ligases which are required for 
either transferring ubiquitin from the E2 enzyme to substrate proteins or facilitating this transfer without 
binding to ubiquitin (12, 16). However, SUMO E3 ligase activity is only observed to be required for 
sumoylation in vivo. These SUMO E3 ligases, for example Siz1 and Siz2 in yeast, serves as a scaffolds 
which promote the contact between SUMO-Ubc9 and the target protein (23). To achieve a highly dynamic 
reversible process, SENP enzymes also play a role in removing SUMO from sumoylated proteins. The yeast 
SENP homologues Ulp1 and Ulp2 are found to be in charge of the de-sumoylation process in that organism 
(24, 25). 
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Figure 6: Sumoylation machinery in yeast (S. cerevisiae) and examples of associated cellular effects. SUMO 
precursor is catalyzed by SUMO protease Ulp1 to expose the C-terminal di-glycine (GG) motif. GG then 
undergoes adenylation which is followed by being transferred to Cysteine (C) residues in SUMO E1 (Uba2/Aos1 
dimer) and then E2 (Ubc9) enzymes. Ubc9 targets SUMO to a lysine (K) residue located usually in a consensus 
motif. In vivo, SUMO E3 ligases (Siz1, Siz2 and Mms21) is observed to facilitate the SUMO conjugation step. 
Examples of the subsequent cellular effects resulting from sumoylation are provided. Reproduced from (20). 
1.6 Sumoylation and Transcription 
Sumoylation is a fundamental regulatory mechanism that controls a wide range of cellular processes such 
as cell cycle progression, DNA repair and chromatin segregation (9, 11, 12, 26). Although sumoylated 
proteins are found to be widespread, those involved in transcription, for example, GTFs, co-regulators and 
subunits of RNAPII, form one of the largest classes of SUMO targets both in yeast and mammalian cells 
(10, 26, 27). Through a number of proteomics studies, numerous SUMO-targeted proteins were identified, 
including GTFs and RNAPII subunits, were identified with high probability (28, 29, 30, 31) (Table 2). In 
the vast majority cases, sumoylation of transcription factors is associated with transcription repression 
through different SUMO-mediated mechanisms (27). For example, sumoylation of the transcription factor 
Elk-1 induces the recruitment of histone deacetylase HDAC-2. This results in reducing histone acetylation 
and subsequent transcription repression (32). However, sumoylation of some gene-specific transcription 
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factors can activate transcription (33). One of the well-illustrated studies found that sumoylation of 
transcription factor Ikaros serves as a derepression mechanism leading to transcription activation (34). In 
this case, the interaction between Ikaros and two co-repressors, Sin3 and NuRD, is blocked due to the two 
sumoylated lysine residues at the N-terminus of Ikaros.   
 
Table 2: High-probability SUMO acceptor sites on general transcription factors (GTFs) and RNAPII subunits. 
Polypeptide sequences for GTF subunits that had been identified as SUMO targets in previous proteomics studies 
were analyzed by SUMOplot tool to identify likely sumoylation sites. Rpb1 and Rpb4 SUMO acceptor sites were 
identified in published studies without SUMOplot analysis (29, 31). 
 
GTF SUBUNIT SITE SEQUENCE 
TFIIA Toa1 89 NSSEFNIKEENTGNE 
149 ADVTSQPKIEVKPEI 
153 SQPKIEVKPEIELTI 
TFIID Taf7 146 SGISIKWKNERHAVV 
330 VSSWENFKEEPGEPL 
343 PLSRPALKKEEIHTI 
Taf8 205 ITDLKTIKKEIVKES 
351 LPKVQKLKKEKIRMA 
TFIIF Tfg1 60 NSRGSLVKKDDPEYA 
91 GRSNVKVKDEDPNEY 
497 KESEQRIKKEMLQAN 
574 KENESPVKKEEDSDT 
658 NTVPSPIKQEEGLNS 
733 GNDHMELKKE***** 
Tfg2 296 IKSIRMPKKEILDYL 
359 RPEYKKLKEEERKAT 
TFIIE Tfa1 434 SNTSNDVKQESINDK 
RNAPII Rpb1 1487 VNADLDVKDELMFSP 
Rpb4 83 KHKKKHLKHENANDE 
 
Although sumoylation of transcription factors is usually associated with transcription repression, 
surprisingly, chromatin immunoprecipitation (ChIP) studies revealed that SUMO is detected at 
transcriptionally active gene promoters, including both constitutive and activated inducible promoters (27). 
In contrast, no SUMO was detected at repressed or silent genes. Interestingly, Ubc9 was not found at the 
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promoter of constitutive genes, whereas activation of inducible genes is accompanied by recruitment of 
Ubc9 (27). This suggests that SUMO targets on constitutive promoters were sumoylated prior to their 
association with chromatin, whereas at induced genes, promoter-bound proteins are sumoylation during 
activation. It is paradoxical that a PTM that is associated with transcriptional repression is found at 
promoters of active genes. To resolve this, it will be important to identify SUMO targets associated with 
active gene promoters, and to examine how sumoylation regulates their specific functions at active 
promoters.   
1.7 Sumoylation and Precursor mRNA Splicing 
1.7.1 Maturation of Precursor mRNA via Splicing 
Precursor messenger RNAs (pre-mRNAs), which contain exons and introns, are synthesized by the 
RNAPII-mediated transcription machinery. Then a process known as pre-mRNA splicing is carried out. In 
this process, the spliceosome catalyzes the removal of introns as well as ligation of exons proceeding the 
formation of mature mRNA (35). As a macromolecular complex, the spliceosome consists of five small 
nuclear ribonucleoprotein particles (snRNPs), including U1, U2, U5 and U4/U6, and multiple non-snRNP 
splicing factors. Inside each snRNP, there is one small nuclear RNA (snRNA) or two in the case of U4/U6, 
a set of seven Sm proteins (B/B’, D3, D2, D1, E, F and G) and many particle-specific proteins (36). The 
assembly of the spliceosome starts with recruitment of U1 snRNP to the 5’ splice site (SS) and U2 snRNP 
to the branch site of pre-mRNA. This leads to the formation of pre-spliceosome (also known as complex A) 
(37) (Fig 7). In the next step, U4/U6-U5 tri-snRNP binds to the complex forming the pre-catalytic complex 
B. Complex B then undergoes numerous RNA and protein rearrangements, and consequently becomes a 
catalytically-active complex. This series of conversion of spliceosome allows the first step of the splicing 
reaction to begin. Moving on, more rearrangements are performed to convert complex B to complex C (also 
known as post-spliceosomal complex) in order to catalyze the second step. At this step, introns are removed 
and the flanking 5’ and 3’ exons are joined together. The spliceosome is then disassembled after completion 
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of the two catalytic steps (35, 37).     
 
 
 
 
Figure 7: The involvement of the essential U2 snRNP component SF3B1 in the stepwise pre-mRNA splicing 
process. Binding of U1 snRNP to the 5’ splice site (SS) and U2 snRNP to the branch point site (BPS) of pre-mRNA 
forms the prespliceosome (Complex A). Then, the U4/U6-U5 tri-snRNP is recruited forming the pre-catalytic complex 
B. Numerous RNA and protein rearrangements in complex B convert it to a catalytically activated complex B. This 
series of conversion of spliceosome allows the first step of splicing reaction to begin. More rearrangements are 
performed to convert complex B to post-spliceosomal complex (complex C) in order to catalyze the second step where 
introns are removed and the flanking 5’ and 3’ exons are joined together. The spliceosome is disassembled after these 
two catalytic steps. Reproduced from (37). 
1.7.2 Sumoylation of Splicing Factors 
In addition to its potential roles in regulating transcription initiation, SUMO conjugation has emerged as a 
critical regulatory mechanism of pre-mRNA splicing (35). In mammalian cells, several splicing factors, 
such as members of the heterogeneous nuclear ribonucleoprotein (hnRNP) and serine/arginine-rich (SR) 
protein families are SUMO substrates (35, 38, 39).  
The splicing factor 3B subunit 1 (SF3B1) is a critical component of U2 snRNP. At an early step of the 
splicing reaction, base pairing of SF3B1 to both the 5’ and 3’ sides of the branch point sequence (BPS) 
contributes to the function of pre-spliceosome (37). Moreover, SF3B1 also interacts with other spliceosomal 
13 
 
 
components. These multiple interactions during splicing stabilizes the spliceosome as well as facilitates its 
recognition at the 3’ SS (37). Intriguingly, a recent proteomics study identified SF3B1 as a SUMO target 
with high confidence (28). However, currently no follow-up study has successfully detected or 
characterized sumoylated SF3B1.   
1.8 Objectives and Hypothesis 
In the first of my two projects, I aimed to investigate how sumoylation of Tfg1 affects its properties and 
transcription in yeast. Previous work in the lab identified Lys residues 60 and/or 61 of Tfg1 as the major 
sumoylation site on TFIIF. To follow up on this, we examined Tfg1 sumoylation under different stress 
conditions, and found that a fraction of Tfg1 molecules are constitutively sumoylated under all conditions. 
Additionally, chromatin fractionation showed that both sumoylated and unsumoylated forms of Tfg1 are 
associated with chromatin. Based on the position of the SUMO-modified residues (Lys 60/61), we 
hypothesized that Tfg1 sumoylation may block the Tfg1-RNAPII interaction, which would then interrupt 
the formation of the PIC and eventually inhibit gene transcription. To address this, taking the advantage of 
previous lab work, several yeast mutants were generated that show either increased or decreased levels of 
Tfg1 sumoylation, compared to a wild-type (WT) strain. We tested whether modulated Tfg1 sumoylation 
levels had an effect on its interaction with RNAPII or on the association of Tfg1 and RNAPII with multiple 
constitutive and inducible genes by chromatin immunoprecipitation (ChIP). To further investigate the 
effects of Tfg1 sumoylation on transcription, we examined whether modulating Tfg1 sumoylation affects 
mRNA levels of various constitutive and stress-responding genes.  
Indeed, our results showed that although a sumoylation-blocking mutation (K60,61R) does not alter the 
Tfg1-RNAPII interaction, reducing Tfg1 sumoylation level by deleting the SUMO E3 ligase Siz1 gene 
(siz1∆) showed an influence on the association of Tfg1 with RNAPII. Additional pair of yeast strains, ULP1 
parental strain and ulp1-1 mutant strain, were also used in order to test for the effect of increased Tfg1 
sumoylation on this association. However, no clear result was obtained due to the faintness of immunoblot 
signals as well as the no-antibody control background. Notably, a common thing shared by these mutant 
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strains is that both deletion of SIZ1 and mutation of ULP1 affect numerous additional targets, besides Tfg1, 
indicating that the effects are not necessarily specific to sumoylation of Tfg1. To address this, additional 
work was carried out to generate a yeast strain that expresses an Smt3-Tfg1 fusion protein, which would 
mimic a permanently sumoylated form of Tfg1. Unfortunately, even after many trials and different 
approaches were attempted, the cloning procedures failed, and the fusion strain was not generated. Our 
attempts at examining how Tfg1 sumoylation affects its chromatin occupancy and the occupancy of 
RNAPII by ChIP were difficult to interpret because of inconsistent results after multiple trials. However, 
our analysis of how Tfg1 sumoylation affects mRNA abundancies did show a consist trend. At normal 
temperatures, the mRNA level of both heat shock (hs)-silenced and constitutive genes were higher in a 
yeast strain that shows reduced levels of Tfg1 sumoylation. Interestingly, upon heat shock treatment, the 
mRNA levels of hs-induced, hs-silenced and constitutive genes showed no difference in both WT and tfg1-
K60/61R mutant (MT).    
In my second project, we aimed to confirm that splicing factor SF3B1 is sumoylated in human cells, and 
further, if indeed confirmed, to test how sumoylation of SF3B1 affects splicing and gene expression. The 
hypothesis, based on the fact that SF3B1 was identified as a SUMO conjugate in proteomics studies, is that 
SF3B1 is sumoylated and its sumoylation alters gene expression by regulating splicing efficiency. However, 
our attempts at detecting SF3B1 by immunoblot, in both HEK 293T cells and in HeLa cells stably 
overexpressing expressing Histidine (His)-tagged SUMO, were initially not successful. Once the procedure 
was optimized, however, we were unable to detect sumoylated SF3B1. As a result, we did not proceed with 
this project. 
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Chapter 2: Materials and Methods 
2.1 Yeast Strains 
All yeast (Saccharomyces cerevisiae) strains used in this study are listed in Appendix Table 2. Strains were 
derived from the W303 background strain. All chromosomally Tfg1-6HA-tagged yeast strains were 
generated by homologous recombination, as previously outlined (27). A K. lactis TRP1 (Kl::TRP1) marker 
gene cassette was introduced into the genome adjacent to the 6HA-tag gene. The presence of the 6HA-tag 
was confirmed by PCR and Western blot analysis using an anti-HA antibody. 
2.2 Yeast Media and Growth Conditions 
Yeast cultures (10 – 50 mL) were grown at 30°C in yeast extract peptone dextrose (YPD; 1% yeast extract, 
2% peptone & 2% glucose) or synthetic complete (SC; 0.17% YNB, 0.5% ammonium sulfate & 2% glucose) 
media to an optical density A595 (O.D.) of 0.5-1.0.  
To simulate several stress conditions, after the cultures reached an O.D. of 0.5-0.7, SC media was replaced 
with SC media containing different reagents, as indicated below, and yeast were allowed to continue 
growing for a certain time period depending on the type of the reagents. For high salt conditions, cells were 
treated with either 1 M sodium chloride (NaCl) or 1 M potassium chloride (KCl) for 5 min. For alcoholic 
conditions, cells were treated with 10% ethanol (EtOH) for 60 min. For amino acid starvation, cells were 
treated with 10 µg/mL sulfometuron-methyl (SM) for 20 min. Additionally, for oxidative stress, to the yeast 
culture was added 100 mM hydrogen peroxide (H2O2) for 5 min without replacing the original SC medium. 
For heat shock (hs) conditions, the culture was grown at 37°C for 12 min. 
2.3 Yeast Immunoprecipitation (IP) 
The strains were grown to saturation overnight at 37°C and diluted to an O.D. of 0.25 the next day. For IP, 
all steps were performed at 4°C. After reaching an O.D. between 0.5 – 1.0, the cells were collected by 
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centrifuging at 3000 g for 5 min, and then washed in IP-B+ buffer (20 mM HEPES, pH 7.5, 10% glycerol, 
150 mM NaCl, 1 mM Ethylenediaminetetraacetic acid [EDTA], 1 mM phenylmethylsulfonyl fluoride 
[PMSF], yeast protease inhibitor cocktail, 1 M dithiothreitol [DTT] & 0.25 g N-ethylmaleimide [NEM]/100 
mL buffer). After washing, re-collected yeast cells were resuspended in 0.5 mL of IP-B+ buffer and 
transferred to new microfuge tubes. 0.25 grams of acid washed glass beads were used in vortex 
homogenization for 30 min (vortexed for 15 min, 5 min on ice followed by another 15-minute vortex). The 
lysate was transferred to a new microfuge tube before centrifuging at top speed for 5 min. The supernatant 
was then transferred to a new tube and this step was repeated once. For preparing the input sample, 40 µL 
of lysate was diluted with an equal volume of 2X SDS-PAGE sample buffer (4% sodium dodecyl sulfate 
[SDS], 20% glycerol, 0.02% bromophenol blue, 10% beta-mercaptoethanol & 140 mM Tris-hydrochloric 
acid [HCl], pH 6.8) and was boiled for 3 min. 15 µL of Protein G sepharose beads were pre-conjugated 
with 1 µg of either rabbit anti-human influenza hemagglutinin (HA) epitope tag primary antibody (Novus) 
or mouse anti-8WG16 primary antibody (abcam) for at least 1 hr before mixing with the remaining yeast 
cell lysate. The lysate-bead mixture was then incubated on a rotator overnight at 4°C.  
The next day, beads were washed 4 times with ice-cold IP-B+ buffer plus 1% NP40 followed by two washes 
with ice-cold IP-B+ buffer. Then, samples were boiled in 100 µL 2X SDS-PAGE sample buffer for 3 min 
to release proteins from the beads. Samples were cooled down on ice before loading.  
2.4 Western Blot and Antibodies 
Equal amounts of protein samples were resolved on a SDS-PAGE gel of an appropriate percentage (7.5%, 
10% or 12.5%) and transferred to nitrocellulose membranes (BioShop) followed by incubating in blocking 
buffer (5% milk in 1X PBST [0.05% Tween-20 in 1% PBS (Fisher Scientific)]) for 30 min at room 
temperature. The membranes were then probed with an appropriate primary antibody (HA [1:3000, rabbit, 
Novus; for detection of HA-tagged Tfg1], SUMO1 [1:100, mouse, DSHB U of Iowa; for detection of 
mammalian SUMO1-involved sumoylation], SUMO2 [1:100, mouse, DSHB U of Iowa; for detection of 
mammalian SUMO2-involved sumoylation], SF3B1 [1:3000, rabbit, Abgent; for detection of splicing 
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component SF3B1], Smt3 [1:250, rabbit, Santa Cruz; for detection of sumoylation], 8WG16 [1:3000, 
mouse, abcam; for detection of RNA Polymerase II subunit Rpb1], Histone H3 [1:3000, rabbit, abcam; for 
detection of histone H3], or GAPDH [1:5000, rabbit, Sigma; for detection of GAPDH]), overnight at 4˚C. 
On the next day, the membranes were washed 3 times in 1X PBST for 5 min at room temperature. The blots 
were then incubated with the appropriate HRP conjugated secondary antibody (1:5000 for anti-rabbit IgG 
& anti-mouse IgG; Thermo Fisher Scientific) for 30 min at room temperature. The blots were then washed 
with 1X PBST three times again and the detection was done by incubating blots with chemiluminescence 
solution (ECL; Bio-Rad) for 5 min followed by exposing with a MicroChemi chemiluminescence imager 
(DNR Bio Imaging Systems). 
2.5 Chromatin Fractionation 
Yeast strains were incubated and grown to saturation overnight. On the next day, the cultures were diluted 
in 25 mL at an O.D. of 0.25. After reaching an O.D. of 0.5-0.6, the cells were harvested at 3000 g for 5 min 
at room temperature. They were then resuspended in 6.25 mL of Resuspension Buffer 1 (100 mM PIPES/ 
potassium hydroxide, pH 9.4 & 10 μM DTT), followed by incubation at 30°C for 10 min with agitation. 
The cells were collected (3000 g at room temperature for 5 min) in a 50-mL conical centrifuge tube and 
resuspended again in 2.5 mL of Resuspension Buffer 2 (0.6 M sorbitol & 25 mM Tris-HCl, pH 7.5 in YPD 
medium). Additionally, 10-15 mg/mL of the lytic enzyme zymolyase was added to each sample at this step, 
followed by 20-minute incubation at 30°C with agitation. The cells were again spun down (2000 RPM at 
room temperature for 3 min). The cell pellet was resuspended in 2.5 mL of Resuspension Buffer 3 (0.7 M 
sorbitol & 25 mM Tris-HCl, pH 7.5 in YPD medium), followed once again by incubation for 20 min at 
30°C with agitation. Then, the cells were pelleted by centrifuging at 2000 RPM in room temperature for 3 
min and then washed with 1 mL of lysis buffer (0.4 M sorbitol, 150 mM potassium acetate, 2 mM 
magnesium acetate, 20 mM PIPES/ potassium hydroxide, pH 6.8, 0.1% NP40, 1 mM PMSF, yeast protease 
inhibitor cocktail & 0.25 g NEM/100 mL buffer) three times. Pellets of each sample were then resuspended 
in 400 μL lysis buffer, followed by the addition of Triton-X 100 to a final concentration of 1%. Material 
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was mixed gently and then left on ice for 5 min. 90 μL of this lysed material was removed and an equal 
volume of 2X SDS-PAGE sample buffer (4% SDS, 20% glycerol, 0.02% bromophenol blue, 10% beta-
mercaptoethanol & 140 mM Tris-HCl, pH 6.8) was added to it. This serves as the ‘whole cell extract (WCE)’ 
control. 100 μL of the remaining lysed material was removed and spun down in a microfuge tube at top 
speed for 15 min at 4°C. 95 μL of the supernatant obtained from this spin was transferred to a new tube and 
added an equal volume of 2X SDS-PAGE sample buffer. This serves as the‘soluble extract (Solub.)’. The 
pellet obtained from the spin was washed once with 100 μL lysis buffer and resuspended in 100μL of 2X 
SDS-PAGE sample buffer. This is the chromatin fraction (Chrom.). All of the three fractions (WCE, Solub. 
& Chrom.) were then boiled for 5 min and allowed to cool down. Samples were spun down at top speed for 
1 min before being loaded directly to the SDS gels for western blot analysis, or vortexed well before 
freezing at -20℃.  
2.6 Chromatin Immunoprecipitation (ChIP) and Quantitative PCR (qPCR) 
Yeast strains were grown to saturation overnight. The next day, they were inoculated in 50 mL of YPD 
medium at 30°C and grown to an optical density A595 (O.D.) of 0.5-0.7. The cultures were treated for cross-
linking by 5 mL of a solution containing 1.1% formaldehyde, 100 mM NaCl, 1 mM EDTA and 50 mM 
HEPES-potassium hydroxide, pH 7.5 for 20 min (swirl briefly every 5 min). Cultures were then quenched 
with 7 mL of 2.5 M glycine for 5 min with occasional mixing. The samples were then transferred to a 50-
mL conical tube and centrifuged at 3000 g for 5 min, 4°C. The obtained pellet was washed twice with 50 
mL of ice-cold TBS (20 mM Tris-HCl, pH 7.5 & 150 mM NaCl), followed by washing with ChIP lysis 
buffer (50 mM HEPES- potassium hydroxide, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% 
sodium deoxycholate & 0.1% SDS). Samples were then spun down at top speed for 5 min (4°C). The pellet 
was resuspended in 600 μL of ice-cold ChIP lysis buffer plus PMSF and yeast protease inhibitor cocktail 
and 400 μL (~0.3 g) of chilled acid-washed glass beads were then added. 
To lyse the cells, a bead beating process (three times for 1 min with 1-minute breaks in between) was 
19 
 
 
performed using a Mini-Beadbeater. A 23G-guage needle was then used to poke a hole through the bottom 
of the tube containing the sample. Then poked tubes were placed on top of a 1.5 mL tube within a 14-mL 
culture tube and together spun at 950 g for 4 min (4°C). Samples obtained from this spin were then subjected 
to sonication aiming to shear the chromatin to fragments of ~500bp. Followed by centrifuging the samples 
in a microfuge at 14,000 g, 4℃, for 5 min, 600 μL of supernatant was transferred to a new chilled 1.5-mL 
tube and mixed with 15 μL of 5 M NaCl. 40 μL of the supernatant was stored as Input at -20°C, and the rest 
of the salt-adjusted supernatant was divided in two for immunoprecipitating with two different antibodies 
[1 μg of anti-HA rabbit antibody (Novus) or anti-8WG16 mouse antibody (abcam) pre-conjugated to 15 μL 
of washed magnetic Protein G beads], overnight at 4°C. The next day, a serial of bead washes (1 mL per 
wash per sample) was performed. The first wash used ChIP lysis buffer with 275 mM NaCl, followed by a 
second wash using the ChIP lysis buffer with 400 mM NaCl and then with the third washing buffer (10 mM 
Tris-HCl, pH 8.0, 0.25 M lithium acetate, 1 mM EDTA, 0.5% NP-40 & 0.5% sodium deoxycholate) and 
finally with TE buffer (10 mM Tris-HCl, pH 8.0 & 1 mM EDTA). Between each wash, the samples were 
incubated and rotated at room temperature for 4 min. After these washes, the beads were incubated with 
ChIP elution buffer (50 mM Tris-HCl, pH 7.5, 10 mM EDTA & 1% SDS) for 20 min at 65°C. Samples 
were separated from the beads using a magnet and then transferred to a new tube. Beads were then incubated 
with 250 μL of TE buffer again at room temperature for 4 min and supernatant obtained at this step was 
pooled with previous sample. This serves as the IP samples. Inputs (previously stored at -20˚C) were then 
thawed and mixed with 460 μL of TE buffer. Both IP samples and Input samples were treated with 10 μL 
of 10 mg/mL RNase A (EMD Millipore; 37°C, 30 min) and then 10 μL of 20 mg/mL proteinase K (BioShop; 
42℃, 1 hr). After these treatments, all samples were incubated at 65°C for 4 hours to overnight to reverse 
cross-links. Each ChIP experiment was conducted at least three times. The average of quantitative PCR 
(qPCR) analyses are presented relative to the chromatin occupancy level at an untranscribed region of 
chromosome V (Chr V), with standard deviations shown as error bars. The value for each sample is 
calculated as follows: 
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Percent Chr V levels = 100*2^(-ΔCt[normalized ChIP to Chr V levels]).  
Primer sequences used for qPCR are listed in Appendix Table 3. 
2.7 RNA Extraction and Reverse Transcription-PCR (RT-PCR) 
Yeast strains were grown in 10 mL YPD medium to an O.D. of 0.5-0.6 at 30°C. For heat shock treatment, 
cells were grown at 37℃ (instead of 30℃) for 20 min before harvesting. Samples were pelleted by 
centrifugation at 3000 g, 4°C, for 3 min and washed twice with chilled AE buffer (50 mM sodium acetate, 
pH 5.2 & 10 mM EDTA, pH 8.0; prepare with DEPC-treated [RNase-free] water). The pellet was then 
resuspended in 400 μL of ice-cold AE buffer and thoroughly mixed with 40 μL of 10% SDS, followed by 
the addition of 440 μL of phenol, pH 4.5. Samples were then chilled in a dry ice/ethanol bath (crushed dry 
ice powder mixed with 95% ethanol forming a thick slurry mixture) for 5 min and then transferred to a 
65°C water bath for 5 min. Then a vortex-mixing step was performed for 30 s. After repeating this 
freeze/thaw/vortex cycle, samples were again flash frozen in a dry ice/ethanol bath before centrifuging at 
top speed, room temperature, for 7 min. The aqueous layers were transferred to new tubes for RNA 
precipitation using 50 μL of 3 M sodium acetate, pH 5.2 and 1 mL of chilled absolute ethanol. The RNA 
samples were then left on dry ice for 10 min before spinning down in a microfuge at 14,000 g, 4°C, for 15 
min. The pellet was then washed with 1 mL of chilled 70% ethanol and centrifuged again at top speed for 
5 min. Additional spinning and air-dry steps were performed to remove the residual liquid. The RNA pellets 
were resuspended in 100 μL of diethyl pyrocarbonate [DEPC]-treated water and the concentration was 
measured using the Nanodrop spectrophotometer. 
For reverse-transcription, 24 μg of RNA samples were treated with DNase I (New England Biolabs) and 
approximately 0.72 μg of this DNase-treated RNA was used for cDNA synthesis using the iScript reverse 
transcriptase reaction (Bio-Rad) according to the manufacturer’s instructions.  
For quantification, qPCRs were performed using SYBR green mix (Froggabio) according to the 
manufacturer’s instructions. Transcripts were normalized to 25S rRNA and the levels were calculated by 
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the 2-ΔΔCT method (40). All experiments were performed at least three times and the average values are 
presented with standard deviations shown as error bars. Primer sequences are listed in Appendix Table 3. 
2.8 Genomic DNA Extraction 
Yeast cultures (10 mL per strain) were incubated in the appropriate media overnight to saturation. The cells 
were collected at 3000 g, room temperature, for 5 min the next day. The pellet was washed in 0.5 mL of 
sterile water and spun down again at 3000 g for 2 min, then resuspended in 0.2 mL of extraction buffer (2% 
Triton-X 100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl, pH 8.0 & 1 mM EDTA). Then, 0.3 g of acid-
washed baked glass beads and 0.2 mL of phenol:chloroform (1:1) were added to the samples, followed by 
a 3-min vortex. After adding 0.2 mL of TE, pH 7.4 to the samples, the cells were then centrifuged at top 
speed for 5 min. The aqueous layer was transferred to a new microfuge tube. 1 mL of absolute ethanol was 
then added and the sample was mixed by inversion followed by spinning at 16,100 g for 1 min. The 
supernatant was subsequently removed by decanting, and the pellet was resuspended in 0.4 mL of 1X TE 
(10 mM Tris-HCl, pH 8.0 & 1 mM EDTA, pH 8.0). The samples were then treated with 3μL of 10 mg/mL 
RNase A for 5 min at 37°C. After this incubation, 10 μL of 4 M ammonium acetate and 1 mL of absolute 
ethanol were added to re-precipitate the DNA. Samples were then inverted and centrifuged at 16,100 g for 
2 min. Finally, the supernatant was removed and the pellet was resuspended in 50 μL of TE (stored at -
20°C). 
2.9 Spot Assay (Drop Test) 
Cells were grown in appropriate liquid growth medium overnight, and the O.D. of each culture was 
determined the following morning. Approximately 10,000 cells of each strain were spotted next to each 
other in the first position, and serial five-fold dilutions were spotted in adjacent positions, on appropriate 
solid medium plates. All plates were then incubated at 30°C (unless otherwise stated) and were imaged 
daily for up to 3 days.   
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2.10 Cloning 
Appropriate primers were used in basic PCR amplifications in order to generate desired gene copies 
required for cloning (Appendix Table 4). For each reaction, both forward and reverse PCR primers were 
used to amplify the sequence of one double-stranded DNA template. All reactions were carried out using 
3-STEP standard PCR which contains a denaturation step, an annealing step and an extension step   
(detailed profile shown in Appendix Table 5). Before yeast transformation, PCR products were validated 
by agarose gel electrophoresis followed by purification using GeneJET Gel Extraction Kit (Thermo Fisher 
Scientific). The fusion PCR was performed similarly as described above. For each reaction, both forward 
and reverse PCR primers were used to amplify the sequences of two double-stranded DNA templates which 
were designed to have overlap sequences. First DNA template contains gene encoding Smt3 followed by a 
36-basepair TFG1 gene (downstream of TFG1 start codon). Second DNA template contains gene encoding 
Tfg1-6HA.     
For plasmid preparing, pMGL4 plasmid was first collected using GeneJET Plasmid Miniprep Kit (Thermo 
Fisher Scinetific). Then both pMGL4 (3 μg) and the insert DNA (2-3 μg) obtained from fusion PCR were 
digested by 1.5 μL of the restriction enzyme KpnI (BioLabs) in 50 μL reaction mix containing 5 μL of 10X 
NEBuffer 1.1 (BioLabs) and appropriate amount of dH2O under 37°C for 2 hrs. The obtained digested 
products were validated and purified (same as for PCR product) before ligation. Each ligation reaction was 
carried out in 20 μL of ligation mixture containing 2 μL of 10X T4 DNA ligase buffer, 2 μL of T4 DNA 
ligase, 1 μL of KpnI-digested pMGL4, 10 μL of KpnI-digested Insert DNA and appropriate amount of dH2O. 
Mixture was incubated at room temperature for 10 min, and then, 2.5 μL of the mixture was transferred to 
50 μL of competent E. coli. Next, the new mixture was incubated on ice for 20 min, followed by a 3-min 
incubation at 37°C and then a 5-min incubation on ice. Lastly, mixture was spread onto a Luria broth (LB) 
+ampicillin plate and incubated overnight at 37°C. 
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2.11 Yeast Transformation 
Yeast cultures were inoculated overnight and grown to saturation. On the next day, cultures were diluted in 
10 mL of SC medium and incubated at 30°C until reaching an O.D. of 0.5. The cells were then harvested 
at 3000 g, room temperature, for 5 min and then washed with 10 mL of sterile water. The pellet was 
resuspended in 500 μL of 0.1 M lithium acetate and transferred to a new microfuge tube. A quick spin (15 
s) at 16,100 g was done to pellet cells. This was followed by resuspending the pellet in 500 μL of 0.1 M 
lithium acetate again. For each transformation, 100 μL of the sample was used. For each transformation, 
cells were mixed with Transformation Mix (240 μL of PEG 3500 50% w/v, 36 μL of 1.0 M lithium acetate, 
25 μL of boiled SS-carrier DNA, 40 μL of water & 10 μL of a cleaned PCR product), vortexed vigorously 
for 1 minute and then incubated in a 42°C water bath for 40 min. After this incubation, the samples were 
centrifuged at top speed for 30 s, followed by removal of the transformation mix. The yeast cells were then 
plated onto appropriate solid medium and incubated at 30°C for 3 days. 
2.12 Yeast Colony PCR  
A small amount of the colony from the plate was picked using a pipet tip. Then these cells were transferred 
to a PCR tube containing 20 μL of 20 mM sodium hydroxide and mixed by agitation with the tip. After 
mixing, the PCR tube containing yeast cells was placed in the PCR machine and incubated at 95°C for 45 
min. Meanwhile, for each sample, 25 μL of the PCR mix was prepare which contains14.75 μL of dH2O, 2.5 
μL of 10X PCR buffer (Taq Buffer with Magnesium chloride), 0.5 μL of 10 mM deoxyribonucleotide 
triphosphate, 1 μL of 5 μM Forward primer, 1 μL of 5 μM Reverse primer and 0.25 μL of Taq DNA 
Polymerase. 80 μL of dH2O was added to the incubated mixture followed by a spin at 3000 g for 5 min. 5 
μL of the sample was taken from the top of the mixture and transferred to the PCR mix followed by the 3-
STEP standard PCR (Appendix Table 5).   
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2.13 Mammalian Cell Lines and Media 
HEK 293T cells, HeLa cells and His-SUMO HeLa cells (obtained through Dr. Patricia Richard, Columbia 
University) were maintained in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% 
(v/v) fetal bovine serum (FBS), 100 units/mL of penicillin/streptomycin antibiotics.  
2.14 Mammalian Immunoprecipitation (IP) 
Culture plates containing the growing cell line were washed twice with chilled 1x PBS before being treated 
with 1 mL of lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM Ethylene glycol tetraacetic acid 
[EGTA], 0.1% Triton X-100 & 1 mM DTT) plus 100X mammalian protease inhibitor cocktail and NEM 
(0.03 g for 5 mL). After cells were scraped together and transferred to a microfuge tube, they were rotated 
in the cold room for 20 min. Samples were spun down at top speed, 4°C, for 20 min, followed by transferring 
the supernatant to a new tube. 50 μL of the supernatant of each sample was saved as Input with the addition 
of 50 μL of 2X SDS-PAGE sample buffer (4% SDS, 20% glycerol, 0.02% bromophenol blue, 10% beta-
mercaptoethanol & 140 mM Tris-HCl, pH 6.8). 15 μL of lysis buffer-washed sepharose beads was added 
to the rest of each sample, followed by adding 2 μL of the appropriate antibodies (mouse anti-SF3B1 from 
LSBio) and rotating overnight at 4°C. On the next day, samples were removed by centrifuging at 2600 rpm 
for 1 min. The beads were washed three times in 1 mL of freshly-made lysis buffer with a 5-min incubation 
at 4°C in between. After washing, beads were collected by centrifugation, then 150 μL of 2X SDS-PAGE 
sample buffer was added to each tube, followed by boiling for 4 min and chilling on ice. These samples 
were then loaded on an SDS-PAGE gel for western blot analysis.  
2.15 Immobilized Metal Affinity Chromatography (IMAC) 
Three growing cell lines, including wild-type HeLa cell line, His-tagged SUMO1-expressing Hela cell line 
and His-tagged SUMO2-expressing HeLa cell line, were washed once with chilled 1x PBS. Cells were then 
collected in 1 mL chilled 1XPBS. Input control was prepared by adding 2X SDS-PAGE sample buffer to 
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10% of the collected cells (110 μL) and then boiling for 6 min. The remaining cells were harvested by 
spinning down at 5000 rpm, 4°C, for 5 min. After removing the supernatant, cells were resuspended in 6 
mL Denaturing Lysis Buffer (6 M Guanidinium-HCl, 100 mM disodium hydrogen phosphate-sodium 
phosphate monobasic, 10 mM Tris-HCl, pH 8.0, 5 mM imidazole & 10 mM beta-mercaptoethanol [add 
fresh at time of use]). 75 μL of nickel-nitrilotriacetic acid (Ni-NTA) agarose beads was added to the cell 
lysate before incubating at room temperature for 4 hrs. After incubation, four washing steps were performed. 
In each step, beads were washed for 5 min at room temperature in 750 μL of the appropriate buffer and 
collected by spinning at 3500 RPM, room temperature, for 4 min and then at 5600 RPM, for 5 min. Beads 
were first washed with Denaturing Lysis Buffer without imidazole followed by Buffer A pH 8.0 (8 M urea, 
100 mM disodium hydrogen phosphate-sodium phosphate monobasic, 10 mM Tris-HCl, pH 8.0 & 10 mM 
beta-mercaptoethanol [add fresh at time of use]), Buffer A pH 6.3 (8 M urea, 100 mM disodium hydrogen 
phosphate-sodium phosphate monobasic, 10 mM Tris-HCl, pH 6.3, 10 mM beta-mercaptoethanol [add fresh 
at time of use] & 0.2% Triton X-100) and Buffer A pH 6.3 (8 M urea, 100 mM disodium hydrogen 
phosphate-sodium phosphate monobasic, 10 mM Tris-HCl, pH 6.3, 10 mM beta-mercaptoethanol [add fresh 
at time of use] & 0.1% Triton X-100). Proteins were eluted with 75 μL of Elution Buffer (200 mM imidazole, 
150 mM Tris-HCl, pH 6.7, 30% glycerol, 5% SDS & 720 mM beta-mercaptoethanol [add fresh at time of 
use]) at room temperature for 20 min. Samples were added with 4X SDS-PAGE sample buffer (8% SDS, 
40% glycerol, 0.04% bromophenol blue, 5% beta-mercaptoethanol & 240 mM Tris-HCl, pH 6.8) and boiled 
for 5 min before loading. 
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Chapter 3: Results 
3.1 Sumoylation of GTF/RNAPII Subunits  
To investigate the involvement of sumoylation in gene transcription, we examined a panel of GTF/RNAPII 
subunits for their sumoylation level. We used a Tagging - Immunoprecipitation - Immunoblot (Tag-IP-IB) 
procedure to confirm sumoylation of the protein of interest (Fig 8). Taking the advantage of HA-tagging 
system, we fused a 6xHA-tag (6HA) to each of the tested GTF/RNAPII subunits. This allows us to 
separately immunoprecipitate (IP) all proteins of interest through a single HA-IP experiment. The extracted 
proteins were then probed with Smt3 (yeast SUMO) and HA-tag antibodies. Both sumoylated and 
unmodified forms of proteins can be detected in HA blot whereas Smt3 blot reveals not only the sumoylated 
proteins of interest but, potentially, other associated sumoylated components that co-IP with the tagged 
proteins. 
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Homologous Recombination 
28 
 
 
Figure 8: Determination of whether the proteins of interest are sumoylated using Tagging-
Immunoprecipitation-Immunoblot (Tag-IP-IB) procedure. (1) STEP1: To generate a yeast strain expressing the 
protein of interest tagged with 6xHA tag, a “tagging cassette” that consist of 6xHA tag coding sequence and the K. 
lactis TRP1 (Kl::TRP1) marker gene is amplified by PCR. Primers used in this amplification contain 45 bases of 
sequence matching sequence upstream and downstream of the stop codon of the gene of interest. (2) STEP2: Taking 
advantage of homologous recombination, the stop codon of the gene of interest is replaced by the amplicon during 
yeast transformation. Transformed yeast cells are selected using medium lacks Tryptophan. (3) STEP 3: The newly 
generated yeast strain undergoes IP procedure. The protein of interest fused with 6xHA tag is pulled down at this step 
and then examined by HA and SUMO immunoblot. In the example shown, lane 1 shows no sumoylated form of the 
protein of interest, while the protein in lane 2 shows two sumoylated isoforms (asterisks) as well as the unmodified 
form. Depending on the degree of sumoylation of the protein of interest, some sumoylated isoforms are not detectable 
by HA immunoblot. 
 
Four GTF subunits, including Toa1 (subunit of TFIIA), Taf7 (subunit of TFIID), Tfg1 (subunit of TFIIF) 
and Tfa1 (subunit of TFIIE), and, as a positive control, the RNAPII largest subunit, Rpb1, were tagged with 
6HA in our experiment. Each of these GTF subunits had been previously identified as putative SUMO 
targets in large-scale proteomics analyses, and Rpb1 sumoylation had previously been confirmed and 
studied (31) (Table 2). Immunoblotting for the HA-tag confirmed the presence of each of the subunits in 
the tagged strains (Fig 9). Among the panel of IPs, multiple sumoylated proteins were detected in the Smt3 
blot, including relatively strong signals for proteins that corresponded in size to sumoylated Tfg1 (~142 
kDa [130 kDa unmodified Tfg1 plus 12 kDa for the Smt3]) and the positive control, sumoylated Rpb1 
(~287 kDa [275 kDa unmodified Rpb1 plus 12 kDa for the Smt3]; arrows in Fig 9). A smear or ladder of 
bands seen in the Smt3 immunoblot of Tfg1 likely represents multiple poly- or multi-sumoylated forms of 
Tfg1. Correspondingly, at least two modified forms of Tfg1 were detected in the HA blot in addition to the 
major, likely unmodified, form of the polypeptide. Further experiments, including the mutational analysis 
described below, confirmed that these bands correspond to sumoylated Tfg1 (see below). Interestingly, 
although Smt3-conjugated Toa1 was not detected, multiple sumoylated proteins were found in the Toa1-IP, 
possibly reflecting sumoylated proteins that interact with TFIIE (red-circled in Fig 9). Overall, our results 
show that among all the GTF subunits tested, Tfg1 has the highest potential to be a significant SUMO target. 
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We then focused our experiments on investigating sumoylation of this TFIIF subunit.    
 
 
 
Figure 9: Testing sumoylation level of a panel of GTF/RNAPII subunits. 6HA-tagged GTF subunits (Toa1, Taf7, 
Tfg1 and Tfa1) and RNAPII largest subunit Rpb1 were pulled down by HA-IP. Western blot probing for SUMO (Smt3; 
left) revealed the level of sumoylation of each protein. Both Tfg1 and Rpb1 showed significant sumoylation levels 
(black arrow). Other sumoylated components that interact with these subunits were also detected (red rectangle). HA 
blot (right) confirmed the presence of each subunits. A wild-type (WT) yeast strain with no 6HA-tagged proteins was 
used as a control. 
3.2 Sumoylation of Tfg1 
3.2.1 Tfg1 is the Major Sumoylated Subunit of TFIIF 
Knowing that Tfg1 is one of three TFIIF subunits, we wanted to see whether the other two subunits, Tfg2 
and Tfg3, are also highly sumoylated. Three yeast strains expressing Tfg1-6HA, Tfg2-6HA and Tfg3-6HA, 
respectively, were generated and tested by HA-IP. Immunoblot results indicated a successful pulldown of 
all three subunits (Fig 10). The control strain, which lacks any HA-tagged proteins, showed no band as 
expected, but both Tfg1 and Tfg2 sumoylation were observed in Smt3 blot. However, Tfg1 has a much 
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higher level of sumoylation compared with that of Tfg2. Additionally, we did not detect sumoylation of 
Tfg3. Thus we concluded that Tfg1 is the major sumoylated TFIIF subunit.  
 
 
 
 
Figure 10: Tfg1 is the major sumoylated subunit of TFIIF. Yeast strains expressing Tfg1-6HA, Tfg2-6HA or Tfg3-
6HA were used in HA-IP which was followed by immunoblotting for Smt3 (SUMO) and HA-tag. HA blots validated 
the successful immunopurification of each TFIIF subunit. Smt3 blot showed Tfg1 was sumoylated significantly higher 
than the other two subunits (white arrow). A wild-type (WT) yeast strain with no 6HA-tagged proteins was used as a 
control. (Result obtained from Russell Bahar) 
 
As TFIIF is an essential component of the transcription machinery that assembles on gene promoters, we 
wished to determine whether sumoylated or unmodified forms of Tfg1 are associated with chromatin. Two 
yeast strains, both producing Tfg1-6HA, were tested by chromatin fractionation analysis, including an ulp1-
1 mutant strain and an isogenic ULP1 wild-type (parental) strain. Whole cell extract (WCE), and soluble 
(Solub.) and chromatin-associated (Chrom.) fractions were isolated and analyzed by immunoblot with 
antibodies for HA, GAPDH, and histone H3 (Fig 11). A band at ~110 kDa in the HA immunoblot confirmed 
the presence of unmodified Tfg1 in WCE and in both soluble and chromatin fractions (Fig 11). A slower-
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migrating HA signal corresponding to monosumoylated Tfg1 was also observed in these two fractions 
(Solub. and Chrom.), which indicates that both sumoylated and unsumoylated forms of Tfg1 are found on 
chromatin.  
 
 
 
Figure 11: Sumoylated Tfg1 presents in both soluble and chromatin fractions. Two yeast strains, one expressing 
wild-type Ulp1 (ULP1-wt) and the other expressing a partially defective form of Ulp1 (ulp1-1) which results in 
increased global levels of sumoylation, were used for determining the location of both unmodified (black arrow) and 
sumoylated (higher molecular weight forms) Tfg1. Chromatin fractionation followed by immunoblotting for HA-tag 
shows both forms of Tfg1 can be found in soluble extract (Solub.) as well in the chromatin fraction (Chrom.). The 
overall amount of Tfg1 can be detected in whole cell extract (WCE). GAPDH and histone H3 serve as controls for 
soluble fraction and chromatin fraction, respectively. 
 
To confirm that the higher molecular weight forms of Tfg1 correspond to sumoylated Tfg1, the ulp1-1 strain 
was included. Ulp1 is one of two major yeast desumoylation enzymes, and the ulp1-1 mutant displays 
significantly reduced protease activity, resulting in higher levels of sumoylation on many proteins. 
Consistent with this, in our HA immunoblot analysis, the ladder of bands that we attributed to sumoylated 
Tfg1 were indeed more prominent in the ulp1-1 mutant strain (Fig 11). Sumoylation can affect protein 
localization and thus, by assessing ulp1-1 mutant, we wished to see whether altered sumoylation affects the 
association of Tfg1 with chromatin. Our result shows that, comparing with the wild-type ULP1 parental 
strain, the increased sumoylation level on Tfg1 had no effect on the localization of both forms of Tfg1 (Fig 
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11). Histone H3, a control for proteins associated with chromatin, was shown to be absent in soluble extract, 
and GAPDH, which is predominantly cytoplasmic, was mostly absent from the chromatin fraction. 
Unexpectedly, we also observed a weak band for GAPDH in chromatin fraction. GAPDH is commonly 
used as a control for the soluble fraction during chromatin fractionation. However, other study showed that, 
although most GAPDH is present in the cytoplasm, it can also be found in membranes, the nucleus and 
cytoskeletal structures (41). As a result, the detection of chromatin-associated GAPDH may due to the 
strongly sensitive GAPDH antibody. To conclude, we reasoned that both sumoylated and unmodified Tfg1 
were located in soluble fraction and on chromatin to a similar extend. The chromatin association of Tfg1 is 
therefore not dependent on sumoylation or altered by artificially increasing its sumoylation level. 
3.2.2 Effects of Different Stress Conditions on Tfg1 Sumoylation  
Rapidly growing yeasts are sensitive to the changes in growth conditions (42). Under stress conditions, 
yeast cells have to balance the cellular growth and the stress response. To defend against different stresses, 
yeast cells correspondingly alter the transcriptome, such as by activating stress-response genes and 
repressing stress-silenced genes, in order to maintain proper cellular functions. As one of the essential 
components of the PIC, the functions of Tfg1 are critical for changes in gene transcription under stress 
conditions. Because sumoylation is known to have the ability to alter protein functions, it was surmised that 
the level of Tfg1 sumoylation might change in response to stress, in order to regulate its function and help 
overcome stress-induced defects.  
To test this, first, a yeast strain expressing Tfg1-6HA was grown until reaching the exponential state, in 
which yeast cells are considered to be rapidly growing. Then, multiple stress treatments, including high salt 
concentration, alcohol, heat, oxidization and amino acid starvation, were performed to simulate different 
stress environments. Cells were cultured in SC medium with or without different treatments, for varied 
durations. We isolated the cell lysate immediately after finishing stress treatments and performed IP-
immunoblot for detection of Tfg1 sumoylation. Compared with the control where yeast cells were cultured 
under normal growth conditions, high salt concentrations (SC+1 M NaCl/1 M KCl) did not affect Tfg1 
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sumoylation (Fig 12A). Similarly, no change was observed in the level of Tfg1 sumoylation under 
conditions with either heat shock (37 °C) or alcohol stress (SC+10% EtOH). This indicates that, under 
conditions where the transcriptome is changed due to the activation of heat shock-induced/alcohol-response 
genes and the repression of heat shock-silenced/alcohol-silenced genes, the level of Tfg1 sumoylation is 
not affected. Sulfometuron-methyl (SM) interrupts the biogenesis of isoleucine and valine leading to amino 
acid starvation (43). Our result showed that treating cells with 10 μg/mL SM did not change Tfg1 
sumoylation levels (Fig 12A). Notably, alcohol stress led to a significant decrease in yeast growth rate and 
the level of both sumoylated and unmodified Tfg1 detected were much lower in the alcohol-treated sample 
than in the others. To further analyze the result, we performed a quantification of HA blot, and determined 
the ratio of sumoylated Tfg1 to total Tfg1 in each treatment (Fig 12B). Yeast cells under all stress conditions, 
even the 10% EtOH environment, showed a similar level of sumoylated Tfg1. Taking together, this 
experiment suggests that the sumoylation of Tfg1 is not affected by different stresses.  
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Figure 12: Tfg1 sumoylation does not appreciably change under different stress conditions. A) Yeast strain 
expressing 6HA-tagged Tfg1 was cultured and treated with different stress conditions: salt stress (1 M NaCl and 1 M 
KCl), alcohol stress (10% EtOH), heat shock (37°C) , oxidative stress (100 mM H2O2) and amino acid starvation stress 
(10 μg/mL SM), as well as the treatment duration are labeled above HA blot. Cell lysates were prepared after 
treatments followed by HA-IP and immunoblot. HA blot shows both sumoylated and unmodified (black arrow) Tfg1. 
Probing Smt3 further reveals Tfg1 sumoylation level. GAPDH serves as loading control. B) Bar graph shows the 
relative sumoylated Tfg1 level under different stress conditions. Quantification of immunoblot (panel A) was analyzed 
by ImageJ. The ratio of sumoylated Tfg1/total Tfg1 (y axis) was calculated using Excel. Stress conditions was labeled 
on x axis. No appreciably change in Tfg1 sumoylation was observed.   
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3.3 Identifying the Major Sumoylated Site of Tfg1 
3.3.1 Lysine 60 and 61 are the Predominant Sumoylated Residues of Tfg1 
We focused on determining the major sumoylated site of Tfg1 in order to better understand the role of Tfg1 
sumoylation. A previous cross-link-mass spectrometry study showed that Tfg1 Lysine residues 60 and 61 
can cross-link with RNAPII subunit Rpb2, indicating that these lysines may be important for TFIIF-RNAPII 
interaction (5). It is possible that PTM of these two lysines can affect this interaction during transcription. 
Indeed, Lysine 61 was also found to be acetylated and to serve as a potential ubiquitination target with high 
confidence (44, 45). All these findings directed our focus to these two lysine residues. Aiming to test 
whether Tfg1 Lysine 60 and 61 (K60,61) can be sumoylated, a yeast strain with a mutated version of 6HA-
tagged Tfg1 was generated. In this strain, both lysines were mutated to arginine (K60,61R), thus preventing 
these residues from becoming sumoylated. Then, this strain was compared with a yeast strain containing 
6HA-tagged wild-type Tfg1. Immunoblotting of HA showed that similar levels of Tfg1 and Tfg1 mutant 
were pulled down through IP (Fig 13). However, as shown in the SUMO immunoblot of the IP, the K60,61R 
mutation almost abolished Tfg1 sumoylation, suggesting that lysine 60 and/or 61 is the major sumoylated 
site of Tfg1. Because we were unable to successfully generate yeast strains with either a K60R or K61R 
single mutation, it remains unclear whether both lysines are sumoylated or only one of them is modified. 
Nonetheless, we successfully narrowed down the major Tfg1 sumoylation site to Lysine 60 and 61.  
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Figure 13: Lysine 60 and/or 61 is the major sumoylated site of Tfg1. Yeast strains with TFG1-6HA and tfg1-
K60,61R-6HA genes respectively were used in an HA-IP which was followed by immunoblotting for Smt3 (yeast 
SUMO) and HA-tag. HA blots confirm that the immunopurification of Tfg1 was successful. The Smt3 (SUMO) blot 
shows that K60,61R (lysine to arginine) mutation dramatically reduces Tfg1 sumoylation (red rectangle). A wild-type 
yeast strain (W303) with no 6HA-tagged proteins was used as a control. (Result obtained from Akhi Akhter) 
3.3.2 The K60,61R Mutation Does not Affect Yeast Growth 
Previously we showed that different stresses do not affect Tfg1 sumoylation (Fig 12). Since Tfg1 K60,61 
was identified as the predominant sumoylation site, we wished to study whether blocking Tfg1 sumoylation 
by the K60,61R mutation affects yeast cell growth patterns under normal and stress conditions. To answer 
this, a yeast growth assay (drop test) was performed. A pair of yeast strains, TFG1-6HA and tfg1-K60,61R-
6HA, were grown to the same culture density and serial dilutions were prepared. Droplets of the serially-
diluted yeast cultures were plated onto media plates (minimal medium, SC) with different stress reagents 
or on an SC plate incubated at 37°C. The stress reagents include salt (1 M NaCl and 1 M KCl), alcohol (7% 
EtOH), peroxide (1 mM H2O2) and an amino acid biogenesis inhibitor (10 μg/mL SM). We observed a very 
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similar growth pattern for both strains under all stress conditions, as well as in two control conditions (rich 
medium, YPD and minimal medium, SC) after incubating for three days (Fig 14).  
 
 
 
 
Figure 14: Sumoylation-deficient Tfg1 mutant presents no defect in growth. Yeast strains expressing Tfg1-6HA 
or Tfg1-K60,61R-6HA were cultured for drop test preparation. Cultures underwent a serial dilution and then were 
spotted either on SC medium plates with different stress reagents or on an SC plate incubated at 37°C. The stress 
conditions, including salt stress (1 M NaCl and 1 M KCl), alcohol stress (7% EtOH), heat shock (37°C), oxidative 
stress (1 mM H2O2) and amino acid starvation stress (10 μg/mL SM), are labeled. Images of yeast colonies were 
captured by scanning after incubation at 30°C or 37°C for 3 days. Colonies inoculated on YPD and SC plates serve as 
control growth conditions. Both yeast strains show similar growth pattern under each stress condition indicating that 
the K60,61R mutation does not affect yeast growth rate.  
 
Interestingly, SM strongly inhibited the cell growth of both strains to a same extent. Aside from this observation, 
our drop test result shows that blocking Tfg1 sumoylation by mutating K60,61 does not affect the growth rate of 
yeast.  
3.4 Effects of Tfg1 Sumoylation on the TFIIF-RNAPII Interaction 
As mentioned above, Tfg1 K60,61 was revealed as one of the contact sites for TFIIF-RNAPII interaction 
during transcription initiation (1, 5). To test how the K60,61R mutation affects this interaction, in particular 
the Tfg1-RNAPII association, reciprocal IPs were conducted. HA-IP allowed us to pull down Tfg1 and 
associated proteins, such as RNAPII subunits Rpb1 and Rpb2. The 8WG16 antibody, which recognizes the 
RNAPII CTD repeat YSPTSPS of Rpb1, was used to IP and detects RNAPII. When comparing Tfg1-6HA 
and Tfg1-K60,61R-6HA IPs, although there is a lower level of sumoylated Tfg1 in the tfg1-K60,61R-6HA 
38 
 
 
strain, the amount of Tfg1-associated RNAPII was not different (Fig 15A). A similar result was observed 
when we pulled down Rpb1 and detected associated Tfg1. The TFG1-6HA wild-type strain and tfg1-
K60,61R-6HA mutant strain exhibited the same level of RNAPII-interacted Tfg1 (Fig 15B). Thus we 
reasoned that blocking Tfg1 sumoylation has no effect on the Tfg1-RNAPII interaction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39 
 
 
 
 
 
 
 
Figure 15: The effects of Tfg1 sumoylation on TFIIF-RNAPII interaction. Yeast strains with either increased 
(ulp1-1 TFG1-6HA) or decreased (tfg1-K60,61R-6HA, siz1∆ TFG1-6HA) Tfg1 sumoylation were tested by 
reciprocal IP, using an HA antibody and 8WG16 antibody, which recognizes the largest subunit of RNAPII, 
Rpb1 (HA-IP [panel A] and RNAPII-IP [panel B]). IPs were then analyzed by immunoblot with HA and 8WG16 
antibodies, as well as with an antibody that recognizes the third largest subunit of RNAPII, Rpb3. Controls 
included a wild-type strain with no HA-tag (WT), the ULP1-wt strain, and a no antibody control (No Ab) 
performed using the ulp1-1 strain.  
A 
B 
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Another way to potentially block Tfg1 sumoylation is through deleting SIZ1, a nonessential gene that 
encodes a major yeast SUMO E3 ligase. A yeast strain with a SIZ1 deletion (siz1∆) could theoretically 
inhibit sumoylation of Tfg1 at all acceptor sites, in addition to Lysine 60 and 61. In fact, the siz1∆ strain 
showed a near complete blocking of Tfg1 sumoylation, as determined by the apparent absence of higher-
molecular weight forms of Tfg1 in an HA immunoblot of IPed Tfg1-6HA (Fig 15A). Interestingly, in the 
siz1Δ strain, a significantly lower level of Tfg1-associated RNAPII was detected (Fig 15A). To further 
determine the effects of altered Tfg1 sumoylation on TFIIF-RNAPII interaction, additional yeast strains 
were tested in this reciprocal IP: the ulp1-1 strain that expresses a mutant form of the desumoylation enzyme 
Ulp1 and its isogenic ULP1 wild-type counterpart. As expected in the ulp1-1 mutant strain, a higher level 
of sumoylated Tfg1 was detected, as determined by increased levels of higher molecular weight forms of 
Tfg1 in the HA blot (Fig 15A). Notably, unlike other HA-tagged strains used, less Tfg1, both unmodified 
and modified forms, was pulled down in ULP1 parental strain and ulp1-1 mutant strain (Fig 15A). 
Consequently, in the ULP1 parental strain, a faint coIPed RNAPII signal was detected in the Tfg1-6HA IP, 
whereas no RNAPII band was detected in the ulp1-1 strain. Because the signal was too faint to be detected, 
quantification of immunoblot results was not able to be carried out. In order to improve this results and to 
examine the effect of elevated Tfg1 sumoylation on Tfg1-RNAPII interaction, following this experiment, 
several trials of HA-IP were repeated aiming to obtain quantifiable results. However, in all trials, a strong 
background was observed in no-antibody control (No Ab), on both HA blot and RNAPII blot, which largely 
reduces the confidence of quantification analysis. As a result, the clear effect of increased Tfg1 sumoyaltion 
by mutating desumoylation activity of Ulp1 on Tfg1-RNAPII interaction remains unrevealed.  
In spite of the alterations of Tfg1-RNAPII interaction observed in the siz1∆ mutant strain, we have to 
consider the global effects induced by this mutation. In this case, not only Tfg1 sumoylation is changed, 
but sumoylation of numerous other target proteins will also be affected. These proteins include, for example, 
other GTFs and RNAPII subunits. Thus the changes in Tfg1-RNAPII interaction in these yeast mutants 
may be contributed by the alteration of sumoylation of other substrates. Although our data suggests that 
sumoylation of Tfg1 specifically does not affect the TFIIF-RNAPII interaction, it appears that global 
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changes to sumoylation levels can regulate the interaction and, therefore, possibly transcription. 
3.5 Effects of Tfg1 Sumoylation on Gene Transcription 
3.5.1 Effects of Tfg1 Sumoylation on TFIIF and RNAPII Association with Chromatin 
As described previously, both TFIIF and RNAPII bind to promoters to induce gene transcription. RNAPII 
is associated with the DNA template during the entire transcription process (initiation, elongation and 
termination) whereas TFIIF mainly functions during initiation and transiently facilitates early elongation 
steps (3, 46). According to this, we wanted to determine the effect of changed Tfg1 sumoylation on TFIIF 
and RNAPII chromatin occupancy. Chromatin immunoprecipitation (ChIP) was performed followed by 
quantitative polymerase chain reaction (qPCR) analysis. We tested relative chromatin occupancies of Tfg1-
6HA, Tfg1-K60,61R-6HA, and RNAPII on constitutively transcribed genes PMA1, at its promoter and 
ORF (open reading frame), and ADH1, at its promoter. Additionally, a constitutively silent gene, STL1 
(osmosis-responding gene), was included as a negative control. At PMA1 and ADH1 promoters, both Tfg1-
6HA and Tfg1-K60,61R-6HA showed significantly high occupancy compared to background signals 
detected at input samples and in a control strain that lacks an HA tag, indicating that 6HA-tag was efficiently 
IPed, as expected (Fig 16). Further supporting that the ChIP procedure was effective, only background 
levels of Tfg1 and RNAPII were detected on the silent STL1 promoter (i.e. equal to the input control). 
Blocking Tfg1 sumoylation, however, did not have an obvious implication on TFIIF-DNA interaction at 
both PMA1 and ADH1 promoters, as the level of occupancy for wild-type Tfg1 and the K60,61R mutants 
were not statistically significantly different with the exception of a minor reduction of Tfg1-PMA1 ORF 
association in tfg1-K60,61R-6HA mutant strain (Fig 16). Similarly, RNAPII-DNA association at the ADH1 
promoter and the PMA1 promoter and ORF was not affected by the sumoylation-blocking mutations of 
Tfg1. In summary, our data suggests that Tfg1 sumoylation has no apparent significant effect on both TFIIF- 
and RNAPII-chromatin association. However, the ChIP quantification results include large error bars which 
reflect a lack of consistency among the six independent ChIP-qPCR replicates that we performed. This 
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prevents us from drawing firm conclusions from this analysis. 
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Figure 16: Effect of Tfg1 sumoylation on TFIIF and RNAPII chromatin occupancy. ChIP followed by qPCR 
amplification was used to analyze how altered Tfg1 sumoylation levels affect TFIIF and RNAPII association with 
chromatin, using HA and 8WG16 antibodies. Yeast strains used include a wild-type strain with no HA-tag (WT) and 
the TFG1-6HA and tfg1-K60,61R-6HA strains. Bar graphs show relative chromatin occupancies of TFIIF and RNAPII 
at the PMA1 (housekeeping gene) promoter and ORF, and the STL1 (osmosis-responding gene) and ADH1 
(constitutive gene for alcohol dehydrogenase) promoters. STL1 was used as a negative control, as it is repressed under 
normal growth conditions.promoter was the control for repressed gene. Results were normalized to a non-transcribed 
region of Chromosome V (ChrV). ChIP-qPCR data and analyzed by Excel. Data are represented as mean +/- standard 
deviation of six independent experiments with p values labeled above. Asterisk indicates statistically significant values 
(Student’s t-test with p < 0.05).  
3.5.2 Effects of Tfg1 Sumoylation on RNA Expression 
To explore how Tfg1 sumoylation alters gene transcription, we measured steady state mRNA levels of a 
number of sample genes in yeast strains expressing Tfg1-6HA or Tfg1-K60,61R-6HA by RT-qPCR. Strains 
were grown either at the normal growth temperature (30°C) or at an elevated temperature (37°C), to 
examine effects of both constitutively expressed genes and genes induced by heat shock (hs). Under normal 
growth conditions, blocking Tfg1 sumoylation resulted in an apparent higher level of RNA expression of 
all genes of interest (Fig 17). Statistical analysis (Student’s t-test) of three replicates, however, indicated 
that only SSA4 (hs-induced gene) and PYK1 (constitutive gene) showed a statistically significant difference 
when grown at 30°C. As expected, heat shock treatment led to strong activation of hs-induced genes 
(HSP12 and SSA4) and a significantly lower RNA expression of hs-silenced genes (PHO5 and SAH1) in 
both yeast strains compared with the result of normal growth condition. In contrast, the RNA abundance of 
constitutive genes (PMA1 and PYK1) were not changed to the same extent. Although our data suggests that 
Tfg1 sumoylation has an inhibitory role in RNA expression at some genes, additional repeats of this analysis 
will be needed to determine whether this is a statistically significant general effect of Tfg1 sumoylation. 
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Figure 17: Effect of Tfg1 sumoylation on RNA expression under normal growth and heat shock (hs) conditions. 
Yeast RNA extraction followed by RT-qPCR amplification was done to analyze how RNA abundance changes as a 
result of decreased Tfg1 sumoylation. Yeast strains used include TFG1-6HA (TFG1-WT) and tfg1-K60,61R-6HA (tfg1-
MT) strains. RNA levels were examined at the ORF regions of heat shock-induced genes (HSP12 and SSA4), heat 
shock-silenced genes (PHO5 and SAH1) and constitutive genes (PMA1 and PYK1). Normal growth temperature is 
30°C and heat shock temperature is 37°C. RNA levels are presented normalized to the 25S rRNA and relative to their 
level in the Tfg1-WT-expressing strain. Data are represented as mean +/- standard deviation of three independent 
experiments with asterisk indicating statistically significant values (Student’s t-test with p < 0.05).  
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3.6 Attempting to Generate an SMT3-TFG1 Fusion Yeast Strain 
An ulp1-1 strain was used to study the effects of increased Tfg1 sumoylation levels in our previous 
experiments. However, no clear result of how reduced desumoylation activity in the ulp1-1 mutant affects 
Tfg1-RNAPII interaction was obtained. In addition, the effect of mutating Ulp1 is very likely to be 
widespread, and not limited to just Tfg1. To improve our results by ruling out the global effects caused by 
malfunctioning Ulp1, we attempted to generate a yeast strain expressing an Smt3-Tfg1 fusion protein. This 
fusion would allow us to simulate permanently sumoylated Tfg1 without affecting other SUMO targets. 
Thus, this new strain, once obtained, could be used for investigating the effects of increased Tfg1 
sumoylation on multiple aspects of gene transcription, including TFIIF-RNAPII interaction, chromatin 
association and RNA expression.  
The first strategy used to generate the fusion is shown in Fig 18A, and involves two yeast transformations 
(Fig 18A). A URA3 marker gene was amplified by PCR and then transformed into diploid yeast strain 
W303 which contains two copies of wild-type TFG1 gene, aiming to replace one copy of TFG1 gene 
through homologous recombination. The presence of URA3, which encodes orotidine 5'-phosphate 
decarboxylase (ODCase), allows successfully transformed yeast cells to grow on standard SC medium 
plates lacking uracil (SC-URA). Thus, positive selection was performed by taking the advantage of URA3 
marker. Three colonies were taken from the SC-URA transformation plate and tested for the presence of 
URA3 gene by yeast colony PCR. An image of the agarose gel showed that all three colonies (named 
yYD004A, B and C) were successful transformed (Fig 19A).  
Before the second transformation, we needed to construct a DNA fragment that consists of the SMT3 open 
reading frame fused to the TFG1-6HA gene sequence (SMT3-TFG1-6HA) and including flanking sequences 
(“homology arms”) that match sequences surrounding the TFG1 locus, which are needed for homologous 
recombination at that site (Fig 18A). SMT3 and TFG1-6HA genes were amplified respectively by PCR and 
validated using agarose gel electrophoresis (Fig 19B). The products were then used as templates for fusion 
PCR. To gain a best fusion PCR efficiency, three amplifications with different SMT3/TFG1-6HA template 
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ratios were carried out. Fusion PCR product from all three reactions were examined by gel electrophoresis 
(Fig 19B). Among all amplifications, a template ratio of 1:2 (SMT3 to TFG1-6HA) resulted in the best PCR 
efficiency. After purification, the fusion PCR product was introduced into yYD004A cells which were 
randomly selected from the first transformation.  
Since the URA3 gene product ODCase converts 5-fluoroorotic acid (5-FOA) into a toxic compound leading 
to cell death, SC medium containing 5-FOA was used to select cells in which the URA3 marker was 
successfully replaced by the SMT3-TFG1-6HA gene. After transformation, two colonies (named Colony A 
and B) were observed on the 5-FOA-containing medium plate and were tested for the presence of either the 
SMT3-TFG1-6HA fusion gene or URA3 by isolating genomic DNA (gDNA) and performing gene-specific 
PCRs. In additional to these colonies, gDNA of yYD004A was examined as a positive control for URA3 
gene and a negative control for the fusion gene. Neither of the colonies derived from successful 
transformation, as indicated by the absence of fusion gene (Fig 19C). Moreover, the absence of URA3 gene 
in both colonies indicates that the URA3 marker was indeed lost during the transformation, but not through 
replacement with the SMT3-TFG1-6HA cassette. As a result of this failed transformation, and multiple 
additional unsuccessful attempts, this strategy for generating the Smt3-Tfg1 fusion protein-expressing yeast 
strain was not pursued. 
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Figure 18: Schematics for generating Smt3-Tfg1 fusion protein-expressing yeast strain. Two cloning methods 
were attempted to generate a new yeast strain expressing Smt3-Tfg1-6HA. A) A diploid yeast strain W303 containing 
two copies of wild-type TFG1 gene is used in the first transformation. The URA3 marker, which encodes orotidine 5'-
phosphate decarboxylase (ODCase), is introduced to replace one copy of the TFG1 gene. URA3-expressing yeast is 
then selected on medium lacking Uracil (SC-URA). The second transformation replaces the URA3 marker with a copy 
of the SMT3-TFG1-6HA fusion gene. Successfully transformed yeast cells are then selected using medium containing 
5-fluoroorotic acid (5-FOA) because ODCase converts 5-FOA into a toxic substrate leading to yeast cell death. 
Selected diploid cells are then sporulated and haploid progeny are tested for viability. B) Vector plasmid pMGL4 is 
digested with the KpnI restriction enzyme. The fusion PCR product (SMT3-TFG1-6HA), with KpnI sticky ends, is 
then be ligated to the digested plasmid. Reconstructed plasmid is transformed into bacteria. The fusion gene is then 
amplified in bacteria and collected by miniprep-scale DNA preparation. Lastly, collected products are transformed 
into yeast cells allowing these cells to express Smt3-Tfg1-6HA fusion protein. 
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Figure 19: Generation of SMT3-TFG1-6HA yeast strain by transformation with fusion PCR product. Two yeast 
transformations were involved in this cloning procedure. A) The URA3 marker (804bp) was amplified by PCR using 
plasmid pRS316 as template and validated by agarose gel electrophoresis. This PCR product was then transformed 
into the diploid yeast strain W303, and transformation product strains, named YYD004A, B and C, were tested for the 
presence of URA3 gene by colony PCR. All three strains showed successful transformation. B) Genes for SMT3 
(~306bp) and TFG1-6HA (~2.5kbp) were amplified by PCR separately and then used as templates for fusion PCR. 
Three Smt3 to Tfg1-6HA template ratios were used: 1:1, 1:2 and 1:3. Obtained fusion PCR products were run on an 
agarose gel to validate the size of the DNA fragments. A band approximately 2.7kbp in length was observed indicating 
a successful fusion PCR. C) Fusion PCR product (SMT3/TFG1-6HA template ratio 1:2) was used to transform strain 
YYD004A. Two colonies (Colony A and B) were observed on plate and tested for the presence of SMT3-TFG1-6HA 
fusion DNA sequence. Neither URA3 marker gene nor the fusion gene was present in either colony. Genomic DNA of 
YYD004A served as a positive control of for the presence of the URA3 gene. 
C 
B A 
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An alternative procedure was attempted, in which the SMT3-TFG1-6HA cassette would be cloned into an 
expression plasmid, which could then be transformed into yeast (Fig 18B). In this strategy, the fusion 
cassette would be generated with flanking sequences containing the KpnI restriction site, and the product 
would be subcloned into plasmid vector pMGL4 at the KpnI site. To validate KpnI digestion of the vector, 
uncut and digested versions of the plasmid were examined by agarose gel electrophoresis side by side. KpnI 
digestion resulted in a linear form of pMGL4 (~7.14kbp) which moved slight slower than the uncut 
supercoiled form (Fig 20A). A DNA band shown at the very top of the gel indicated an open-circular form 
of plasmid. Then, TFG1-6HA (~2.5kbp) and SMT3-TFG1-6HA (~2.7kbp) gene, both with flanking KpnI 
restriction sites, were obtained by normal PCR and fusion PCR, respectively, as we did in the first cloning 
procedure. TFG1-6HA gene will serve as a control in later steps. After purification, both PCR products 
were digested with KpnI, but analysis by electrophoresis showed that, although TFG1-6HA and SMT3-
TFG1-6HA genes were successfully amplified, KpnI digestion led to the appearance of unexpected products, 
indicated by smears of bands located below 2000bp marker (Fig 20B). To eliminate these unwanted DNA 
products, we performed gel extraction to purify the desired gene fragments. These purified DNAs would 
then be used to ligate with KpnI-digested pMGL4. However, the concentration of the purified insert was 
too low to be useful for ligation. Because of the low yield of the purified insert fragments, and because of 
the appearance of the unidentified digestion products, we decided not to proceed with this strategy until 
these issues are resolved.  
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Figure 20: Generation of SMT3-TFG1-6HA yeast strain by transformation with plasmid. Inserts were prepared 
for generating a recombinant plasmid in this cloning procedure. A) Plasmid pMGL4 (~7.14kbp) was used as vector 
and digested by the KpnI restriction enzyme. Both intact plasmid and the digested version were analyzed by agarose 
gel electrophoresis. The open-circular form (black arrow) and the supercoiled form of pMGL4 were observed on gel. 
KpnI-digested plasmid was in a linear form and thus ran slightly slower than the supercoiled form. B) TFG1-6HA 
(~2.5kbp) and SMT3-TFG1-6HA (~2.7kbp) DNA fragments were amplified by PCR and then digested by KpnI. Both 
undigested and digested DNA pieces were validated by an agarose gel where digested DNA fragments ran slightly 
faster than the original copies. Unspecific bands of unknown origin were detected, possibly indicating unexpected 
cutting occurred during KpnI digestion.  
3.7 Characterizing SF3B1 Sumoylation   
The experiments described above focused on effects of sumoylation during transcription initiation in yeast, 
by examining GTFs and RNAPII. Moving on, we were also curious about eukaryotic cells use SUMO 
modifications to regulate pre-mRNA splicing. Specifically, we were interested in investigating the effects 
of sumoylation of a splicing factor on pre-mRNA processing events. A previous proteomics study, in which 
numerous putative SUMO conjugates were identified in HeLa cells, determined that the human protein 
SF3B1, a critical component of the U2 snRNP splicing complex, has a high probability of being sumoylated 
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(28, 37). Thus, we intended to confirm and characterize SF3B1 sumoylation in HeLa cells. We obtained an 
antibody for SF3B1, and performed IP-immunoblot analysis to detect sumoylated forms of the splicing 
factor. A conspicuous band around 150kDa was observed in both input and IP samples of SF3B1 blot 
confirming the successful pulldown of SF3B1 (Fig 21). However, although sumoylated proteins were 
detected in input samples, immunblots of the SF3B1 IP with SUMO1 and SUMO2 antibodies showed no 
signals, indicating that there is no detectable modified SF3B1 in these cells. Because the absence of a 
sumoylated SF3B1 band may due to the undetectable low level of endogenous modified SF3B1, we 
repeated the analysis in other HeLa-derived cell lines that overexpress His-tagged SUMO1 or SUMO2, 
which we anticipated could elevate SF3B1 sumoylation levels. First, both His-tagged cell lines were 
validated for their SUMO overexpression level. Because of the contamination issue of the wild-type HeLa 
cell culture, we used wild-type HEK 293T cell line as the control in immunoblot analysis instead. Compared 
with His-SUMO1 HeLa cells, which showed a slightly higher level of SUMO1 than the wild-type HEK 
293T cells, His-SUMO2 HeLa cells showed a significant higher level of SUMO2 expression than wild-type 
cells (Fig 22A). As a result, a following IMAC taking the advantage of His-tag affinity was carried out 
using His-SUMO2 HeLa cell line and wild-type HeLa cell line. Enrichment of His-tag signal observed on 
His-tag blot indicated a successful purification of His-tagged targets (Fig 22B). A higher level of SUMO2, 
although shown as a smear, was detected in His-SUMO2 HeLa cells indicating the successful 
overexpression. Unfortunately, no sumoylated SF3B1 was IPed in either wild-type HeLa cells or SUMO2-
overexpressing HeLa cells indicating using SUMO2-overexpressing cells did not improve the IP procedure 
in this experiment. In summary, we were unable to confirm that SF3B1 is sumoylated in mammalian cells. 
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Figure 21: Characterization of SF3B1 sumoylation. SF3B1 was immunopurified from Hela cells and analyzed by 
immunoblot with antibodies for SF3B1, SUMO1 and SUMO2. Although SF3B1 was successfully purified, neither 
SUMO1 nor SUMO2 signals were observed in the IP, indicating that no detectable sumoylated SF3B1 was found. 
Typical SUMO1 and SUMO2 smears are present in input samples, including a strong band (black arrow) which 
corresponds in size to Ran GTPase Activating Protein 1, which is one of the most heavily sumoylated proteins known. 
A no antibody IP control was included. 
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Figure 22: Characterization of SF3B1 sumoylation in SUMO2-overexpressing cell line. A) Validation of His-
SUMO1 and His-SUMO2 HeLa cell lines by western blotting His-tag. Cell lysate of HEK 293T cell (WT) served as 
control. His-SUMO2 HeLa cells showed a significant overexpression of SUMO2. B) Proteins modified by His-
SUMO2 were purified by IMAC and analyzed by immunoblot with antibodies for SUMO2, SF3B1, His-tag and 
tubulin (loading control). Wild-type HeLa cell line (WT) served as a control. His-SUMO2 HeLa cells showed an 
enriched His-tag signal indicating a successful purification of His-tagged targets. Overexpression of SUMO2 was 
observed as expected in His-SUMO2 HeLa cells. However, SF3B1 was only observed in input indicating a failed IP. 
Tubulin signal was only observed in input as expected. 
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Chapter 4: Discussion 
Sumoylation is a post-translational modification (PTM) modifies proteins by a reversible covalent 
conjugation process. Through attachment of SUMO to acceptor proteins, protein-protein interactions, 
protein stability and intracellular localization can be altered. This modification is largely involved in 
regulating multiple cellular events including cell cycle progression, transcription and DNA repair. In 
particular, one of the largest groups of SUMO target includes proteins involved in transcription and its 
regulation. In most cases, the effect of sumoylation of transcription factors is the repression of gene 
expression. However, it may also activate transcription in a gene-dependent manner. Previous proteome-
wide studies identified multiple GTF subunits, including TFIIF subunit Tfg1, as highly confident SUMO 
targets (Table 2). Thus, we tested multiple GTF subunits for their level of sumoylation. We used a 
previously-studied and confirmed SUMO target, Rpb1, as a positive control (31). Our result showed Tfg1 
has a much higher sumoylation level compared with other GTF subunits in normally growing yeast cells 
(Fig 9). This gives us a clue of the involvement of sumoylation in regulating RNAPII-mediated 
transcription.  
To benefit our investigation on how changes in cellular sumoylation levels can affect transcription, in 
particular its effect on the TFIIF-RNAPII interaction, we aimed to characterize Tfg1 sumoylation first. We 
found that, among all three TFIIF subunits, Tfg1 is the most sumoylated (Fig 10). This not only supports 
our result which showed Tfg1 has a higher sumoylation level compared with other GTF subunits, but also 
validated the prediction of others that Tfg1 is a SUMO target with high potential (Table 2). This result 
suggests that sumoylation regulates TFIIF function mainly through Tfg1. As Tfg1 interacts directly with 
RNAPII, and since the interaction of TFIIF and RNAPII is critical during transcription, much of our 
research focused on assessing Tfg1 sumoylation and its effect on the Tfg1-RNAPII interaction.  
To deeply understand Tfg1 sumoylation, we examined it from multiple angles. We determined that the same 
fraction of both chromatin-associated and soluble Tfg1 is sumoylated (Fig 11). Furthermore, unlike what 
others have found, in which the dynamics of intracellular localization of certain transcription factors is 
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regulated by sumoylation, increased Tfg1 sumoylation did not significantly alter its chromatin-association 
pattern (47). As a result, we do not believe that sumoylation affects the subcellular localization of Tfg1, nor 
is it restricted to transcriptionally-engaged forms of TFIIF.  
Moreover, we tested the effects of multiple stress conditions on Tfg1 sumoylation. The transcriptome is 
known to be significantly affected by different environmental factors, such as temperature and oxidizing 
compounds (48). The alteration of gene transcription patterns may be due to the modification of the 
association of TFIIF with RNAPII during transcription initiation, which we speculated might be affected 
by the level of sumoylated Tfg1. The stresses we performed included high salt, alcohol, heat shock, 
oxidative stress and amino acid starvation. By measuring the ratio of sumoylated Tfg1 over total Tfg1 level, 
we showed that the proportion of modified Tfg1 was not influenced by these stress factors (Fig 12). 
Importantly, even 10% EtOH, under which the cell growth rate was significantly reduced, did not lead to 
an obvious change in this ratio compared with all other conditions. This revealed that the level of Tfg1 
sumoylation is likely not involved in stress-induced changes to the transcriptome. Additionally, we used 
the same stress conditions to test for differences in yeast growth rates caused by inhibition of Tfg1 
sumoylation. This took the advantage of our previous generated yeast strain which contains a Tfg1-
K60,61R mutated protein. In this strain, the Tfg1 sumoylation is almost completely blocked due to lose of 
two lysine residues at the major SUMO site and thus it served as a comparison that has depleted Tfg1 
sumoylation (Fig 13). After inoculating for three days, the growth pattern, mainly the size of the yeast 
colonies, was observed to have no difference between TFG1 wild-type and mutant strains under all stress 
conditions (Fig 14). Conclusively, we have demonstrated that altering the level of Tfg1 sumoylation does 
not affect the cellular response to a number of stress conditions, which is consistent with our finding that 
Tfg1 sumoylation levels do not change under those conditions. 
Intriguingly, Lysine 60 and 61 of Tfg1, which is the major site of sumoylation, was previously found to be 
the cross-linking site between Tfg1 and RNAPII subunit Rpb2 (5). We hypothesized that sumoylation of 
Tfg1 Lys 60 and 61 would interrupt its interaction with RNAPII leading to repression of gene transcription. 
Furthermore, we expected that the K60,61R mutation would also impair the interaction and impair 
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transcription. To validate this, we performed reciprocal Tfg1 and RNAPII IPs. Surprisingly, blocking Tfg1 
sumoylation by K60,61R mutation did not affect Tfg1-RNAPII association (Fig 15). This suggests that, 
although Lys 60 an 61 may be involved in the association of TFIIF with RNAPII, they are not critical for 
the interaction which must be stabilized by additional contacts between the proteins. 
To assess how modulating Tfg1 sumoylation can affect the TFIIF-RNAPII interaction without altering the 
Tfg1 amino acid sequence, we performed IP experiments in strains lacking the SUMO ligase Siz1 or 
expressing a partially defective form of the desumoylation enzyme Ulp1 (Fig 15). Deletion of SIZ1 gene 
effectively blocked Tfg1 sumoylation and, interestingly, also resulted in a significant decrease in the Tfg1-
RNAPII interaction. Although this might indicate that Tfg1 sumoylation has a positive role in maintaining 
the interaction, which is opposite to our prediction, it is more likely due to the widespread effect of deleting 
SIZ1, which has numerous targets in addition to Tfg1 and RNAPII. As such, reduced sumoylation of some 
other factor(s) in the siz1Δ strain might indirectly reduce the Tfg1-RNAPII interaction. The ulp1-1 mutant 
strain with an increased level of Tfg1 sumoylation was used to examine the effect of elevated Tfg1 
sumoylation on Tfg1-RNAPII interaction. Unfortunately, it’s hard to give a conclusion for this examination 
because of the lack of confident results, which is due to the faintness of immunoblot signals as well as the 
no-antibody control background.   
As another strategy to examine the role of sumoylation of Tfg1, we attempted to generate a new yeast strain 
that expresses Tfg1 as an Smt3-Tfg1 fusion protein (Fig 18). This strategy has been used by others to study 
the effects of “permanent sumoylation” (49), and, in our case, because all Tfg1 molecules in the cell would 
be covalently attached to SUMO, this theoretically could simulate significantly elevated the level of SUMO 
modified Tfg1 in the cell. Furthermore, the strain would allow us to examine elevated Tfg1 sumoylation 
without affecting other SUMO target proteins. If we had succeeded in generating the strain, we would have 
used it to get an idea of how elevated Tfg1 sumoylation might affect the Tfg1-RNAPII interaction and gene 
transcription. Unfortunately, currently the fusion strain was not able to be generated due to failure of the 
cloning process.  
The final part of our study on Tfg1 sumoylation focused on determining whether the modification affects 
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the association of Tfg1 with its chromatin binding sites or the expression levels of its target genes. Multiple 
ChIP experiments were performed, but because of a high level of inter-experiment variability, results were 
not conclusive in determining whether sumoylation affects binding of Tfg1 or RNAPII to active gene 
promoters. However, when the repeat experiments were taken together, the average occupancies of Tfg1 
and RNAPII were not statistically significantly different in the TFG1 wild-type and tfg1-K60,61R strains 
(Fig 16). We explored whether blocking sumoylation of Tfg1 through the K60,61R mutation might affect 
the expression levels of transcribed genes. Indeed, for a subset of the tested genes, inhibiting Tfg1 
sumoylation resulted in a significant elevation of RNA abundance, although no change was detected at 
other genes (Fig 17). Overall, result of our RNA experiment indicated that, although Tfg1 sumoylation did 
not alter the TFIIF-RNAPII interaction, it may contribute to the repression of transcription through a 
RNAPII-independent mechanism.  
To explore additional roles for sumoylation in the regulation of gene expression, we wished to examine the 
role of sumoylation in pre-mRNA splicing. According to proteomics studies which predicted that the human 
U2 snRNP splicing factor component SF3B1 is a SUMO target with high confidence, we were interested 
in confirming that it is sumoylated and characterize the role of sumoylation in regulating its function. 
However, we were unable to detect SF3B1 sumoylation in cultured cells with either endogenous or 
overexpressed levels of SUMO (Fig 21 & 22). One reason for this is that the level of endogenous 
sumoylated SF3B1 may be cell type-specific or condition-specific. To be clear, this means the endogenous 
sumoylated SF3B1 may be highly expressed in certain cell types or under particular conditions. No 
detection of SF3B1 sumoylation in our results may due to the low level of modified SF3B1 expressed in 
the cell lines tested, or the improper culturing and experimental conditions that do not favor SF3B1 
sumoylation. The lack of anti-SF3B1 with high sensitivity can be another reason for the failed detection of 
SF3B1 sumoylation. Although we attempted to enhance this modification by using HeLa cells that 
overexpress SUMO, it seems to be insufficient to promote SF3B1 sumoylation to a detectable level.      
To summarize our findings, amongst GTFs, TFIIF is relatively highly sumoylated in normally growing 
yeast cells, specifically its largest subunit, Tfg1. A fraction of Tfg1 molecules in the cell is constitutively 
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sumoylated, which is unaffected by exposure to stress. Changes in Tfg1 sumoylation, therefore, are not 
likely the key contributor for the altered transcription that occurs as part of the stress defense. Blocking 
Tfg1 sumoylation, through mutation of Lysine 60 and 61, does not alter the TFIIF-RNAPII interaction, but 
a general decrease in cellular sumoylation levels, through deletion of the SUMO ligase Siz1, does reduce 
the interaction. Although sumoylated Tfg1 is detected on chromatin, blocking the modification does not 
appear to affect chromatin occupancy of Tfg1 or RNAPII at promoters of active genes. However, the 
expression of some genes is elevated in strains expressing the Tfg1 K60,61R mutant, suggesting that the 
modification can have a gene-specific repressive role, through unknown mechanisms as well as the 
chromatin association of TFIIF and RNAPII. TFIIF is highly involved in RNAPII-mediated transcription 
by directly interacting with RNAPII and recruiting it to activated gene promoters. Our results now 
demonstrate that sumoylation can regulate chromatin-associated TFIIF, but since the modification does not 
affect the RNAPII-TFIIF interaction, sumoylation must control other properties of the TFIIF as a 
mechanism of regulating gene expression.   
 
 
 
 
 
 
 
 
 
 
 
59 
 
 
Chapter 5: Future Directions 
Although there are limitations to using a SUMO fusion for studying the role of sumoylation, we expect that 
generating an Smt3-Tfg1-expressing strain would be beneficial to determine what properties of TFIIF are 
enhanced or impaired by the modification. As part of the future directions, more efforts could be put in 
troubleshooting the cloning procedure in order to generate the Smt3-Tfg1 fusion yeast strain. Especially, 
the poor gel purification efficiency should be improved. By solving this, we will be able to get purified 
fusion PCR product at a high enough concentration that can be used in generating the desired reconstructed 
plasmids which then are used to transform yeast cells. If we successfully obtained this new strain, it can be 
examined in comparison to wild-type and tfg1-K60,61R strains in a number of experiments. This would 
allow us to test how dramatically decreased and increased Tfg1 sumoylation affects growth rates, the TFIIF-
RNAPII interaction, recruitment of TFIIF and RNAPII to target gene promoters, and the expression level 
of a number of genes.  
As a result of inconsistent ChIP results, we failed to show a clear change in chromatin association of Tfg1 
and RNAPII at selected gene promoters and ORFs. Though technique troubleshooting may help to improve 
the results, an alternative method that also tests transcription factor/RNAPII-chromatin association may be 
used. Specifically, ChIP-Seq (chromatin immunoprecipitation followed by next generation shot-gun 
sequencing) can be performed. Ideally, this would be performed using TFG1 wild-type, tfg1-K60,61R, and 
the fusion strain described above, to examine how Tfg1 sumoylation alters its global DNA-binding patterns. 
A number of previous studies have found that sumoylation affects the chromatin occupancy of transcription 
factors, and it has been suggested that this is a major role for the modification and a common mechanism 
of regulating gene expression (50). Additionally, RNA-Seq (whole-transcriptome sequencing) would also 
contribute to a wider understand of the regulatory role of Tfg1 sumoylation by examining how altered Tfg1 
sumoylation levels affects the composition of the transcriptome. This will help determine whether effects 
of Tfg1 sumoylation are general or specific to certain groups of genes. 
Much of our analysis focused on the interaction between Tfg1 and RNAPII. However, it will be interesting 
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to look into how sumoylation of Tfg1 might influence protein-protein interactions between TFIIF and other 
proteins, particularly those that compose the transcription pre-initiation complex, including other general 
transcription factors and components of the Mediator complex. To achieve this, we can take the advantage 
of an analytical technique, mass spectrometry (MS) to identify proteins that associate with Tfg1, Tfg1-
K60/61R, or Smt3-Tfg1 after immunopurification from yeast cultures. The MS results will allow us to 
identify, upon decreased or increased Tfg1 sumoylation, whether binding of specific proteins is regulated 
by the modification.  
Overall, the future directions mainly aim to study the effects of Tfg1 sumoylation in a global view, instead 
of focusing on individual genes or specific proteins. We hope that by looking broadly we can shed light on 
the function of Tfg1 sumoylation-directed transcription regulation, which may serve as a clue when more 
generally investigating the effect of sumoylation of other GTFs on gene expression. 
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Appendix 
Table 1: List of selected cross-linked residues within the TFIIF-RNAPII complex. Examples of inter-protein links 
along with the interacting lysine residues are shown. Adapted from (5). 
 
 
 
Table 2: S. cerevisiae strains used in this study. 
 
Strain Genotype 
ERYM552B rpb1-6HA::RPB1 Kl TRP1 
YER023 (W303a) MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 [phi+] 
YFK001I TFA1-6HA::Kl TRP1 
YJB001A TOA1-6HA::Kl TRP1 
YJB002A TFG1-6HA::Kl TRP1 
YJP001A TAF7-6HA::Kl TRP1 
YRB013A tfg1-K60/61R-6HA::Kl TRP1 
YYD001A siz1Δ::KanMX TFG1-6HA::Kl TRP1 
YYD002D TFG1-6HA::Kl TRP1 
YYD003A TFG1-6HA::Kl TRP1 ulp1-1 
YYD004A,B,C TFG1 / tfg1Δ::URA3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inter-protein RNAPII-TFIIF Tfg1 Lys 60 N-terminal region Rpb2 Lys 606 
Inter-protein RNAPII-TFIIF Tfg1 Lys 61 N-terminal region Rpb2 Lys 606 
Inter-protein RNAPII-TFIIF Tfg1 Lys 61 N-terminal region Rpb2 Lys 652 
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Table 3: Primers used for qPCR (ChIP and RT-qPCR). 
 
Target Gene Region Primer Sequence ( from 5’ to 3’) Direction 
ADH1 Promoter GTTTGCTGTCTTGCTATCAA Sense 
GAAAAAGAAACAAGGAAGAA Anti-sense 
Chromosome V 
 (Chr V) 
Untranscibed CATTATCCGTAACGCCACTTT Sense 
CGATCTTAGTTCCAATGGTGAAA Anti-sense 
HSP12 ORF CTCTGCCGAAAAAGGCAAGG Sense 
GACGGCATCGTTCAACTTGG Anti-sense 
PHO5 ORF CACTTTTGCCAACTCGGACG Sense 
AGCATGTCTCTTGGCGTTCA  Anti-sense 
PMA1 Promoter CAATTATGACCGGTGACGAAAC   Sense 
AATCGAAACTAATGGAGGGGAG   Anti-sense 
PMA1 ORF CTGGTCCATTCTGGTCTTCTATC Sense 
TCAGACCACCAACCGAATAAG Anti-sense 
PYK1 ORF AACCCAAGACCAACCAGAGC Sense 
ACGGCGTTGATTGGGTAGTT Anti-sense 
SAH1 ORF GGTAAGGTTGCCGTTGTTGC Sense 
TCGGTAACCAAGACACGAGC Anti-sense 
SSA4 ORF GGCAGAAAAGTTCAAGGCCG Sense 
GCATCCTCTTCACCCACCTT Anti-sense 
STL1 Promoter TGAAACCGCCGGAAGAAGTT Sense 
CCATGGTTGAGTGCCATCCT Anti-sense 
25S ORF TCTAGCATTCAAGGTCCCATTC Sense 
CCCTTAGGACATCTGCGTTATC Anti-sense 
 
 
Table 4: Primers used for PCR during cloning procedure. 
 
Target Gene Primer Sequence ( from 5’ to 3’) Direction 
 
SMT3 
AAGGTTGAAGAATAGCTAGGGAGGCCTATTCGAG
TAAGCGCAAGGATGTCGGACTCAGAAGTCAATCA
AGAAGC 
Sense 
CCCGTTTCTACTGCCTGGTGGATTGCGTCTGGACA
TAATCTGTTCTCTGTGAGCCTCAATAATATCG 
Anti-sense 
 
TFG1-6HA 
ATGTCCAGACGCAATCCACCAGGCAGTAGAAACG
GGGGAGGTCC 
Sense 
TTTAAAGTTTCATTCCAGCATTAGC Anti-sense 
 
URA3 
AAGGTTGAAGAATAGCTAGGGAGGCCTATTCGAG
TAAGCGCAAGGATGTCGAAAGCTACATATAAG 
Sense 
ACGAAAACTAAATAACCTATTAAGTACATAACATT
ATAAACTAACTTAGTTTTGCTGGCCGCATC 
Anti-sense 
 
SMT3-TFG1-6HA 
AAGGTTGAAGAATAGCTAGGGAGGCCTATTCGAG
TAAGCGCAAGGATGTCGGACTCAGAAGTCAATCA
AGAAGC 
Sense 
ACGAAAACTAAATAACCTATTAAGTACATAACATT
ATAAACTAACTTAGCTAGAAGCGTAATCTGGAACG
TC 
Anti-sense 
 
68 
 
 
Table 5: 3-STEP standard PCR profile. 
 
 
 
 
 
 
     TEMPERATURE DURATION 
INITIAL DENATURATION 
94˚C  1:00 
REPEAT FOLLOWING THREE STEPS 30X 
92˚C 0:40 
55˚C 0:40 
72˚C 1:00 
FINAL EXTENSION 
72˚C 5:00 
COOL UNTIL SAMPLES REMOVED 
4˚C - 
